Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FURIN,Furin,Wald ratio,1,1.44 [1.34-1.54],1.63784302102138e-24,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.13 [1.1-1.16],2.18034245313342e-18,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.78 [0.73-0.83],8.67960503061721e-14,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REN,Renin,Inverse variance weighted,4,1.11 [1.06-1.15],3.40358994688752e-06,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.23 [1.12-1.35],6.76061475330988e-06,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.87 [0.82-0.92],9.26176394680539e-06,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.06 [1.03-1.09],2.80890693909989e-05,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFNGR2,Interferon gamma receptor 2,Inverse variance weighted,27,1.03 [1.02-1.05],4.94611313691593e-05,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,8,1.07 [1.03-1.1],5.73522436390093e-05,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,1.48 [1.22-1.79],5.77536439295426e-05,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.85 [0.79-0.92],6.3235735253501e-05,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.93 [0.9-0.97],0.000115528834143025,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.1 [1.05-1.15],0.000119202058020446,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.06 [1.02-1.09],0.000375077392262344,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD27,CD27 antigen,Inverse variance weighted,9,1.07 [1.03-1.1],0.000422129814150542,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SHMT1,"Serine hydroxymethyltransferase, cytosolic",Inverse variance weighted,42,1.04 [1.02-1.06],0.000456666438600594,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS4,Galectin-4,Inverse variance weighted,4,0.87 [0.81-0.94],0.000493790395784375,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.24 [1.09-1.4],0.000651970030924582,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,12,1.09 [1.04-1.14],0.000820140328442589,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.92 [0.88-0.97],0.000859233769937718,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.03 [1.01-1.04],0.000903597930646517,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGR,Tyrosine-protein kinase Fgr,Inverse variance weighted,2,1.23 [1.09-1.39],0.000939683275894226,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PYY,Peptide YY,Inverse variance weighted,6,1.08 [1.03-1.14],0.000990268880575899,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.94 [0.91-0.98],0.00140904358897213,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.79 [0.68-0.91],0.00144698306186364,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,1.1 [1.04-1.16],0.00149034087797988,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KHK,Ketohexokinase,Inverse variance weighted,22,1.07 [1.02-1.12],0.00258241749426484,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,0.79 [0.67-0.92],0.00283431434750371,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.07 [1.02-1.12],0.00297161971474954,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.04 [1.01-1.06],0.00321801667428139,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PSME2,Proteasome activator complex subunit 2,Wald ratio,1,0.83 [0.73-0.94],0.00354708643538814,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RTBDN,Retbindin,Inverse variance weighted,3,0.91 [0.85-0.97],0.0036338632138067,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.2 [1.06-1.35],0.00371475763240483,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SRP14,Signal recognition particle 14 kDa protein,Wald ratio,1,1.4 [1.11-1.75],0.00381672362624077,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1.02 [1.01-1.04],0.00390954911860132,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.96 [0.94-0.99],0.00401330414878048,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.08 [1.02-1.14],0.0047312411358577,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.17 [1.05-1.31],0.00475821791927273,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,1.35 [1.1-1.67],0.00492810942761381,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,32,1.03 [1.01-1.04],0.00493010381213807,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PXN,Paxillin,Inverse variance weighted,26,0.96 [0.93-0.99],0.00508175081876836,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.98 [0.96-0.99],0.0050899599149552,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,0.96 [0.94-0.99],0.00513828631682392,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.93 [0.88-0.98],0.00531828526182027,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.94 [0.9-0.98],0.00534911117686436,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.04 [1.01-1.06],0.00537901136881066,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,POMC,Pro-opiomelanocortin,Inverse variance weighted,2,0.82 [0.72-0.95],0.00641293560594787,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.89 [0.81-0.97],0.00655605014719881,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.85 [0.76-0.96],0.00701011065247471,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MAPK9,Mitogen-activated protein kinase 9,Inverse variance weighted,2,0.87 [0.79-0.96],0.00730461900083464,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.03 [1.01-1.05],0.00744216353937287,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GSR,"Glutathione reductase, mitochondrial",Wald ratio,1,1.06 [1.01-1.1],0.00755483036065131,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,UMOD,Uromodulin,Inverse variance weighted,29,1.03 [1.01-1.05],0.00772154718139986,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TALDO1,Transaldolase,Inverse variance weighted,3,1.15 [1.04-1.28],0.00796329329506945,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.12 [1.03-1.22],0.00812702242176716,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.91 [0.84-0.97],0.00836185858693358,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.04 [1.01-1.06],0.00916835775012449,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,1.28 [1.06-1.54],0.00970328504613838,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,1.04 [1.01-1.07],0.00986893757632053,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHL1,Neural cell adhesion molecule L1-like protein,Inverse variance weighted,16,1.03 [1.01-1.06],0.00994248973006266,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.96 [0.93-0.99],0.0103068139860119,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.9 [0.82-0.98],0.0113940018140274,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Wald ratio,1,0.89 [0.81-0.97],0.0116113565039483,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,0.92 [0.86-0.98],0.0117761922222516,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.89 [0.81-0.98],0.0128950877784825,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,1.44 [1.08-1.93],0.0138880603726995,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,Inverse variance weighted,2,1.14 [1.03-1.26],0.0139407645719038,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1.05 [1.01-1.09],0.0145404760509226,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL8,Interleukin-8,Inverse variance weighted,6,1.15 [1.03-1.3],0.0145678734954699,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,1.02 [1-1.04],0.0149328582445157,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.02 [1-1.04],0.0150219411380332,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,31,0.97 [0.95-0.99],0.0155932553142518,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SORD,Sorbitol dehydrogenase,Inverse variance weighted,3,0.92 [0.86-0.98],0.015917252576142,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,0.95 [0.92-0.99],0.0163711228746949,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PENK,Proenkephalin-A,Inverse variance weighted,19,1.05 [1.01-1.1],0.0165674177723915,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.46 [1.07-2.01],0.0186348628063398,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ABL1,Tyrosine-protein kinase ABL1,Wald ratio,1,1.24 [1.04-1.49],0.0198225482115392,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.97 [0.95-1],0.0198368515533596,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.7 [0.52-0.95],0.0206495042042651,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSS,Cathepsin S,Inverse variance weighted,23,1.03 [1.01-1.06],0.021106163364137,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KYNU,Kynureninase,Inverse variance weighted,8,0.94 [0.89-0.99],0.0215013684756716,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.86 [0.75-0.98],0.0221784689027757,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRSS8,Prostasin,Inverse variance weighted,5,1.1 [1.01-1.2],0.0226042792628197,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.29 [1.04-1.6],0.0228008573184906,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IQGAP2,Ras GTPase-activating-like protein IQGAP2,Inverse variance weighted,2,1.1 [1.01-1.19],0.0234647310050357,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.92 [0.86-0.99],0.0242731497934139,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.92 [0.86-0.99],0.0245871563397836,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RSPO1,R-spondin-1,Inverse variance weighted,5,1.06 [1.01-1.11],0.025481916536176,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EDN1,Endothelin-1,Inverse variance weighted,3,1.06 [1.01-1.12],0.0257011788803771,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.87 [0.76-0.98],0.0265391682888694,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.08 [1.01-1.17],0.0265721947002044,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.06 [1.01-1.12],0.0271227265701892,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.75 [0.58-0.97],0.0279012589189758,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL10,Interleukin-10,Wald ratio,1,0.88 [0.78-0.99],0.0279932688221022,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.08 [1.01-1.16],0.0287892159594901,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1R2,Interleukin-1 receptor type 2,Inverse variance weighted,23,1.03 [1-1.05],0.0288864365122289,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CNTN1,Contactin-1,Inverse variance weighted,22,0.96 [0.93-1],0.029689158733901,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,18,0.95 [0.91-1],0.0297714026537753,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.86 [0.76-0.99],0.0303194898198305,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,1.03 [1-1.07],0.0309873482456467,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PSAP,Prosaposin,Inverse variance weighted,5,1.06 [1.01-1.12],0.0314993878855693,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.04 [1-1.09],0.032821471715051,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSD,Cathepsin D,Inverse variance weighted,17,1.06 [1-1.11],0.0330409225682931,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.2 [1.01-1.41],0.0331785525473747,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.91 [0.83-0.99],0.0332871604848788,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.12 [1.01-1.24],0.0335126431230741,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.89 [0.79-0.99],0.0341799117717829,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.91 [0.83-0.99],0.0342566622773308,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,23,1.03 [1-1.05],0.0350160641577657,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.95 [0.91-1],0.0352656663734829,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.1 [1.01-1.21],0.0363063081494815,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.93 [0.88-1],0.0364204131310131,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.06 [1-1.12],0.0367867385675653,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.17 [1.01-1.35],0.0370214607309414,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSB,Cathepsin B,Inverse variance weighted,26,0.96 [0.93-1],0.0372682276467663,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.98 [0.96-1],0.0376171153128127,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.9 [0.82-0.99],0.0376807562249254,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSO,Cathepsin O,Inverse variance weighted,6,0.94 [0.89-1],0.0381548465440228,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,1.06 [1-1.13],0.038617987921018,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,0.98 [0.97-1],0.0393722619325572,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,0.97 [0.94-1],0.0395713798439482,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FETUB,Fetuin-B,Inverse variance weighted,20,0.97 [0.94-1],0.0398059495347098,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.92 [0.86-1],0.0404076289234722,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLAT,Tissue-type plasminogen activator,Wald ratio,1,1.28 [1.01-1.62],0.0404846947298016,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NECTIN4,Nectin-4,Inverse variance weighted,7,1.04 [1-1.08],0.0415864766145917,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,22,0.98 [0.95-1],0.0416384980200194,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MSLN,Mesothelin,Inverse variance weighted,25,1.03 [1-1.06],0.0418801695219111,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLGN,Calmegin,Inverse variance weighted,23,0.98 [0.96-1],0.0419703463164361,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Wald ratio,1,1.18 [1.01-1.38],0.042171224372206,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.06 [1-1.12],0.0423898165808773,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SELE,E-selectin,Inverse variance weighted,4,0.88 [0.77-1],0.0430053883246261,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,0.99 [0.97-1],0.0436497440127008,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,1.05 [1-1.11],0.0440017993955869,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.02 [1-1.03],0.0441452347537,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Inverse variance weighted,10,0.94 [0.88-1],0.044154405013001,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.05 [1-1.11],0.0445982824555432,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,20,1.03 [1-1.05],0.0447965803097401,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPO,Erythropoietin,Inverse variance weighted,5,0.87 [0.75-1],0.0456223725921795,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.04 [1-1.08],0.0470084850647941,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,1.04 [1-1.08],0.0482640272998143,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.02 [1-1.05],0.0496504450192587,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,0.96 [0.91-1],0.0510926024396527,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,0.9 [0.81-1],0.051475619630459,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1.04 [1-1.09],0.051637266948407,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CFHR2,Complement factor H-related protein 2,Inverse variance weighted,63,0.99 [0.98-1],0.0518833358687673,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GOT1,"Aspartate aminotransferase, cytoplasmic",Wald ratio,1,1.35 [1-1.82],0.0527306313554529,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.95 [0.91-1],0.0532990156887661,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.94 [0.89-1],0.0534364911331754,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MPO,Myeloperoxidase,Inverse variance weighted,11,1.05 [1-1.11],0.0544930420173235,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,10,1.04 [1-1.07],0.0557621715945118,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP10,Stromelysin-2,Inverse variance weighted,22,1.03 [1-1.06],0.0562960248726067,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LMNB2,Lamin-B2,Wald ratio,1,0.75 [0.55-1.01],0.0564234718715331,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,0.98 [0.96-1],0.0583471989006967,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL6,C-X-C motif chemokine 6,Inverse variance weighted,26,1.04 [1-1.07],0.0587414069645857,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.96 [0.91-1],0.0589756496666987,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.96 [0.91-1],0.0592551847559882,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.95 [0.89-1],0.0596733420104392,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.98 [0.95-1],0.059967517398699,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.98 [0.96-1],0.0605225451170488,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MUC13,Mucin-13,Inverse variance weighted,9,1.05 [1-1.1],0.0626450156244785,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.97 [0.94-1],0.0638128687306349,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLXNB2,Plexin-B2,Inverse variance weighted,27,0.99 [0.97-1],0.0641189551677224,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,3,0.78 [0.59-1.02],0.0642583566476604,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FLT4,Vascular endothelial growth factor receptor 3,Inverse variance weighted,15,0.96 [0.92-1],0.0660944748432134,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,10,0.97 [0.93-1],0.0661021696775684,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TCN1,Transcobalamin-1,Inverse variance weighted,29,1.02 [1-1.04],0.0670933643686235,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GRN,Progranulin,Inverse variance weighted,7,1.05 [1-1.11],0.067104589602474,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,0.72 [0.5-1.02],0.0673536892839281,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.96 [0.93-1],0.0675489872507853,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.97 [0.94-1],0.0679578134118977,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,7,1.14 [0.99-1.3],0.0693584350985563,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.07 [0.99-1.15],0.0709876637857744,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.07 [0.99-1.16],0.0712572648391151,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,1.09 [0.99-1.19],0.0713104928847925,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.06 [1-1.13],0.0713688121266107,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.09 [0.99-1.2],0.0733562065448102,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.97 [0.93-1],0.0744667598019064,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.77 [0.58-1.03],0.0745909583289154,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.02 [1-1.04],0.0763435754873796,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PGF,Placenta growth factor,Inverse variance weighted,2,0.75 [0.55-1.03],0.076555319873997,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,12,0.95 [0.89-1.01],0.0774305712607517,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTN,Pleiotrophin,Inverse variance weighted,4,0.91 [0.81-1.01],0.0778768079395405,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [1-1.04],0.0788312277642432,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AMBP,Protein AMBP,Inverse variance weighted,3,1.07 [0.99-1.16],0.0798527394664993,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,21,0.98 [0.96-1],0.0806219839607918,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,0.96 [0.92-1.01],0.080873311781378,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,0.95 [0.89-1.01],0.0817137788559401,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DBI,Acyl-CoA-binding protein,Inverse variance weighted,9,0.95 [0.89-1.01],0.0823161397168171,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPPK1,Epiplakin,Inverse variance weighted,33,0.98 [0.96-1],0.0835337741114398,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,1.05 [0.99-1.11],0.0835925899268978,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CWC15,Spliceosome-associated protein CWC15 homolog,Wald ratio,1,1.21 [0.97-1.51],0.084013493792854,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,36,0.98 [0.95-1],0.0841489779816489,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,0.92 [0.84-1.01],0.0843539359904529,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.96 [0.93-1.01],0.0852247271995972,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.02 [1-1.04],0.0852454436779006,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.36 [0.96-1.93],0.0862561529527545,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GSTA1,Glutathione S-transferase A1,Inverse variance weighted,7,1.13 [0.98-1.29],0.0881933807781046,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.07 [0.99-1.15],0.0888006708977838,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.98 [0.97-1],0.092958286527433,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.05 [0.99-1.12],0.0931594309291407,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,0.98 [0.95-1],0.0953847807921062,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.02 [1-1.06],0.0971544533595098,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCAN,Neurocan core protein,Inverse variance weighted,3,0.93 [0.86-1.01],0.0980107492619153,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.76 [0.55-1.05],0.0982921890093647,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANG,Angiogenin,Inverse variance weighted,19,1.02 [1-1.05],0.100755779042714,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,26,0.98 [0.96-1],0.103353591736783,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C19orf12,Protein C19orf12,Wald ratio,1,0.77 [0.56-1.06],0.104316580398937,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,24,1.02 [1-1.04],0.104368635770427,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.98 [0.96-1],0.104436102701125,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTSL5,ADAMTS-like protein 5,Inverse variance weighted,15,0.97 [0.94-1.01],0.105853807837961,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.02 [1-1.03],0.106904343331064,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.03 [0.99-1.07],0.107161014990865,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EGFLAM,Pikachurin,Inverse variance weighted,19,1.02 [1-1.05],0.107418327886388,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.05 [0.99-1.13],0.107972407723764,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,Inverse variance weighted,14,0.97 [0.93-1.01],0.108992567172558,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ARG1,Arginase-1,Inverse variance weighted,4,0.95 [0.88-1.01],0.111452254528807,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.04 [0.99-1.08],0.111905949561151,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,1.11 [0.98-1.25],0.111916978770646,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.98 [0.95-1.01],0.11201093432038,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD160,CD160 antigen,Inverse variance weighted,11,0.97 [0.94-1.01],0.11268726325049,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GFRAL,GDNF family receptor alpha-like,Inverse variance weighted,33,1.02 [1-1.05],0.113005896155824,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.99 [0.97-1],0.113560356924215,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.98 [0.95-1.01],0.113780819464618,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MAP2,Microtubule-associated protein 2,Wald ratio,1,0.74 [0.5-1.08],0.114150134389808,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.98 [0.97-1],0.11628550226668,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.06 [0.98-1.15],0.116608658424865,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RGMB,RGM domain family member B,Inverse variance weighted,9,0.96 [0.91-1.01],0.116770805214288,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD302,CD302 antigen,Inverse variance weighted,9,0.95 [0.89-1.01],0.11850349398395,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MME,Neprilysin,Inverse variance weighted,3,1.19 [0.95-1.49],0.121390984571903,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MENT,Protein MENT,Inverse variance weighted,3,1.03 [0.99-1.06],0.122146862799988,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.97 [0.93-1.01],0.122395607253491,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.94 [0.87-1.02],0.12368203688708,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.03 [0.99-1.08],0.124374581029735,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HEXIM1,Protein HEXIM1,Wald ratio,1,1.24 [0.94-1.62],0.124605143861204,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KITLG,Kit ligand,Wald ratio,1,0.83 [0.65-1.05],0.124948937227484,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DSC2,Desmocollin-2,Inverse variance weighted,9,0.97 [0.93-1.01],0.1249569625315,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGRN,Agrin,Inverse variance weighted,17,0.97 [0.92-1.01],0.126243896866276,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.98 [0.94-1.01],0.126614283200242,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,0.94 [0.88-1.02],0.127891988363928,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.03 [0.99-1.08],0.130415178084648,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.12 [0.97-1.3],0.130806927261694,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,4,1.05 [0.98-1.13],0.131002853704235,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,5,1.07 [0.98-1.16],0.131075628765996,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NT5E,5'-nucleotidase,Inverse variance weighted,45,1.01 [1-1.03],0.13198201792391,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,F7,Coagulation factor VII,Inverse variance weighted,21,1.02 [0.99-1.05],0.132091977774421,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL17C,Interleukin-17C,Inverse variance weighted,3,1.07 [0.98-1.17],0.132704702932171,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.8 [0.6-1.07],0.134322819769784,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CALCA,Calcitonin,Inverse variance weighted,5,0.88 [0.74-1.04],0.134354333955998,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.02 [0.99-1.06],0.135165094283123,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCN3,CCN family member 3,Inverse variance weighted,19,1.03 [0.99-1.07],0.138072578879478,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH3,Cadherin-3,Inverse variance weighted,2,1.11 [0.97-1.28],0.138514865226139,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.93 [0.84-1.02],0.14036993991929,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.98 [0.96-1.01],0.142636798680457,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,1.05 [0.98-1.12],0.143251066084145,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.03 [0.99-1.06],0.145661291801352,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.15 [0.95-1.4],0.14765115354478,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGA2,Integrin alpha-2,Inverse variance weighted,31,0.98 [0.96-1.01],0.14769969604057,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.01 [1-1.03],0.148423182137597,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAYN,Layilin,Inverse variance weighted,20,0.97 [0.92-1.01],0.150131637092189,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPB1,Carboxypeptidase B,Wald ratio,1,1.09 [0.97-1.21],0.151120657117201,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.1 [0.96-1.27],0.151965389017565,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP6,Gastrotropin,Wald ratio,1,0.94 [0.85-1.02],0.152030922437599,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,0.91 [0.81-1.03],0.152110441470233,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,0.99 [0.97-1.01],0.153679371397572,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,A1BG,Alpha-1B-glycoprotein,Inverse variance weighted,5,1.03 [0.99-1.07],0.154602422676811,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.04 [0.98-1.11],0.157237970862447,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,3,1.06 [0.98-1.16],0.160790033789692,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCN1,CCN family member 1,Inverse variance weighted,2,0.92 [0.83-1.03],0.161032164123525,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,1.03 [0.99-1.08],0.162827181590528,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.97 [0.93-1.01],0.162871399055871,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,1.03 [0.99-1.06],0.163026331712311,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NIT2,Omega-amidase NIT2,Inverse variance weighted,3,0.9 [0.77-1.05],0.163604338257224,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.06 [0.98-1.14],0.165363590131817,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.03 [0.99-1.07],0.165679476040879,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.05 [0.98-1.12],0.166718337094098,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.03 [0.99-1.07],0.167289249291065,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.99 [0.98-1],0.168371338133619,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.97 [0.94-1.01],0.170643133204433,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.06 [0.98-1.15],0.171296415672168,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.97 [0.94-1.01],0.171658635451178,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.96 [0.9-1.02],0.1734334173862,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,1.06 [0.97-1.15],0.173521558729279,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLG,Plasminogen,Inverse variance weighted,20,1.03 [0.99-1.07],0.175077482611122,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPA1,Carboxypeptidase A1,Inverse variance weighted,2,0.95 [0.88-1.02],0.175203105488679,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CFD,Complement factor D,Inverse variance weighted,11,1.03 [0.99-1.08],0.177580995347589,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK15,Kallikrein-15,Inverse variance weighted,20,0.99 [0.98-1],0.182310647926162,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.03 [0.98-1.08],0.183475173846405,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOA2,Apolipoprotein A-II,Wald ratio,1,0.88 [0.73-1.06],0.184245400963996,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.03 [0.99-1.07],0.184755619725384,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.22 [0.91-1.63],0.185103654350127,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.03 [0.99-1.07],0.185105956391239,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DDT,D-dopachrome decarboxylase,Inverse variance weighted,2,0.96 [0.91-1.02],0.185289235773457,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,S100A11,Protein S100-A11,Wald ratio,1,0.94 [0.87-1.03],0.188277946483594,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGA5,Integrin alpha-5,Wald ratio,1,0.87 [0.71-1.07],0.18898473751673,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.02 [0.99-1.05],0.192424379589972,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FBLN2,Fibulin-2,Inverse variance weighted,11,1.02 [0.99-1.06],0.19260057939024,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.04 [0.98-1.11],0.192753264608712,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EZR,Ezrin,Wald ratio,1,1.16 [0.93-1.45],0.192987781898008,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.97 [0.92-1.02],0.193103290334846,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.91 [0.78-1.05],0.193983715058119,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,1.02 [0.99-1.06],0.196431215662119,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,1.03 [0.98-1.08],0.199270867770635,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDHR2,Cadherin-related family member 2,Inverse variance weighted,2,0.93 [0.83-1.04],0.199677665362231,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,1.02 [0.99-1.06],0.200820771303325,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,6,1.04 [0.98-1.1],0.200850779062493,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BSG,Basigin,Wald ratio,1,1.06 [0.97-1.16],0.20107790161652,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HJV,Hemojuvelin,Wald ratio,1,1.04 [0.98-1.12],0.201205009283988,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.05 [0.97-1.14],0.202664482533881,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.16 [0.92-1.45],0.203402806807856,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.02 [0.99-1.04],0.203746894766885,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AREG,Amphiregulin,Inverse variance weighted,3,1.06 [0.97-1.16],0.213702951357929,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.04 [0.98-1.12],0.215166585026175,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHGA,Chromogranin-A,Inverse variance weighted,3,0.95 [0.87-1.03],0.215202371016253,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.11 [0.94-1.3],0.216528244617609,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.01 [0.99-1.03],0.218283452750742,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.01 [0.99-1.03],0.21928610725795,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,43,1.01 [0.99-1.03],0.219601980391004,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.86 [0.67-1.09],0.21998272146031,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.92 [0.8-1.05],0.22212854318151,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,0.99 [0.98-1],0.226141290720485,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.05 [0.97-1.13],0.226962382216399,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.02 [0.99-1.05],0.227069907062915,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CR2,Complement receptor type 2,Inverse variance weighted,6,0.97 [0.91-1.02],0.227724763604609,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.1 [0.94-1.29],0.229912689147022,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.07 [0.96-1.19],0.233070866719678,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1RAP,Interleukin-1 receptor accessory protein,Inverse variance weighted,24,1.01 [0.99-1.02],0.235075740372406,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CX3CL1,Fractalkine,Inverse variance weighted,9,0.97 [0.91-1.02],0.237110995427222,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,1.03 [0.98-1.07],0.237208272212796,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,INHBC,Inhibin beta C chain,Inverse variance weighted,29,0.98 [0.95-1.01],0.24210751403728,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,21,1.02 [0.98-1.06],0.24507899701776,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.95 [0.88-1.03],0.245953087328672,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.99 [0.97-1.01],0.246731737437677,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.99 [0.98-1.01],0.247644988659219,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.02 [0.99-1.05],0.248354519573163,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.03 [0.98-1.07],0.251889397083282,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,1.18 [0.89-1.56],0.255059051163131,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.04 [0.97-1.12],0.257833304932086,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.02 [0.99-1.05],0.25930061102152,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,1.12 [0.92-1.35],0.259996801021319,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PI3,Elafin,Inverse variance weighted,10,1.02 [0.98-1.07],0.262203877858085,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDKN1A,Cyclin-dependent kinase inhibitor 1,Inverse variance weighted,3,1.05 [0.97-1.13],0.262628652757664,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP1,Interstitial collagenase,Inverse variance weighted,31,0.98 [0.95-1.01],0.263706935439883,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,1.03 [0.98-1.09],0.264761195523235,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCAM2,Neural cell adhesion molecule 2,Inverse variance weighted,30,0.99 [0.97-1.01],0.266003716889496,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PBLD,Phenazine biosynthesis-like domain-containing protein,Inverse variance weighted,23,0.99 [0.96-1.01],0.269235092246243,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,6,1.04 [0.97-1.12],0.272202724437211,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.96 [0.9-1.03],0.272653133943823,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.12 [0.91-1.38],0.272956736503517,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,3,0.97 [0.92-1.03],0.27615068811652,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCG2,Secretogranin-2,Wald ratio,1,1.15 [0.89-1.49],0.277078283417314,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.01 [0.99-1.03],0.278107400780525,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.08 [0.94-1.25],0.280976623271963,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.02 [0.98-1.07],0.281143436009905,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.01 [0.99-1.03],0.282784302709029,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,0.94 [0.84-1.05],0.28463458552004,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,0.99 [0.97-1.01],0.285670613318255,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH2,Cadherin-2,Inverse variance weighted,3,1.14 [0.9-1.44],0.287100651927356,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,UPB1,Beta-ureidopropionase,Inverse variance weighted,3,1.07 [0.94-1.21],0.289187872816596,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK8,Kallikrein-8,Inverse variance weighted,12,1.02 [0.98-1.07],0.291706426842422,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SELP,P-selectin,Inverse variance weighted,8,0.98 [0.93-1.02],0.293977382675946,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.98 [0.94-1.02],0.294369152517618,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.8 [0.52-1.22],0.294902778462867,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1.01 [0.99-1.04],0.295176601694397,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PROK1,Prokineticin-1,Inverse variance weighted,25,1.02 [0.98-1.07],0.295967967055843,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Inverse variance weighted,6,0.95 [0.87-1.04],0.297255286204017,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.98 [0.94-1.02],0.298261137451264,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PGA4,Pepsin A-4,Inverse variance weighted,2,1.09 [0.93-1.28],0.29850789428018,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CNTN3,Contactin-3,Inverse variance weighted,14,0.98 [0.95-1.02],0.298851417556347,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CST7,Cystatin-F,Inverse variance weighted,39,1.01 [0.99-1.04],0.29957422086671,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.02 [0.99-1.05],0.300215572708765,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.95 [0.87-1.04],0.300382708887901,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.95 [0.87-1.04],0.300886979846595,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,16,1.01 [0.99-1.04],0.30267795764937,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,1.01 [0.99-1.04],0.302981863392441,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DCXR,L-xylulose reductase,Inverse variance weighted,2,1.06 [0.95-1.18],0.304149127301771,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,17,1.02 [0.99-1.05],0.305670108828607,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.11 [0.91-1.35],0.305699606260114,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.99 [0.97-1.01],0.30600437210666,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.86 [0.64-1.16],0.313137326745179,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.99 [0.97-1.01],0.315661848865766,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,0.97 [0.92-1.03],0.315795069135609,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.98 [0.95-1.02],0.316660147885043,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPE,Carboxypeptidase E,Inverse variance weighted,11,0.98 [0.95-1.02],0.317797321307066,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.88 [0.69-1.13],0.317904346368338,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1.13 [0.89-1.44],0.317906571511692,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CNTN5,Contactin-5,Inverse variance weighted,28,1.01 [0.99-1.04],0.320594001059227,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.99 [0.96-1.01],0.323524267674769,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CFI,Complement factor I,Inverse variance weighted,6,0.96 [0.89-1.04],0.325976328742547,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,1.04 [0.96-1.13],0.329427005023086,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.91 [0.75-1.1],0.333616141477204,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,9,1.03 [0.97-1.11],0.33369253069575,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OSM,Oncostatin-M,Wald ratio,1,1.09 [0.91-1.3],0.337119875402921,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1.01 [0.99-1.02],0.339095529476671,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.02 [0.98-1.06],0.340311396369458,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AFM,Afamin,Inverse variance weighted,5,1.09 [0.91-1.3],0.342193559386723,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPIND1,Heparin cofactor 2,Wald ratio,1,1.07 [0.93-1.24],0.342526525471377,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CST3,Cystatin-C,Inverse variance weighted,10,1.02 [0.98-1.06],0.342789847308434,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,1.01 [0.99-1.02],0.344359652331779,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.02 [0.98-1.06],0.345462136853594,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.99 [0.97-1.01],0.346001906697944,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.91 [0.76-1.1],0.346469971615381,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,1.09 [0.91-1.32],0.347454914005677,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,S100A12,Protein S100-A12,Inverse variance weighted,3,1.03 [0.97-1.1],0.348104074990001,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.96 [0.89-1.04],0.349669836691656,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TMSB10,Thymosin beta-10,Wald ratio,1,0.91 [0.74-1.12],0.351847129407038,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.93 [0.81-1.08],0.353360340372451,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.03 [0.97-1.1],0.356309246400584,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.07 [0.93-1.22],0.356642897674273,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADH1B,All-trans-retinol dehydrogenase,Inverse variance weighted,3,0.95 [0.86-1.06],0.357885959631228,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.01 [0.98-1.04],0.359390908466132,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRISP2,Cysteine-rich secretory protein 2,Inverse variance weighted,40,1.01 [0.99-1.04],0.359481817153777,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.06 [0.93-1.22],0.359690896758097,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSV,Cathepsin L2,Inverse variance weighted,11,1.03 [0.97-1.08],0.363158463128329,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.01 [0.99-1.03],0.363770167253328,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.99 [0.97-1.01],0.364506318766091,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.98 [0.94-1.02],0.365760630989494,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,0.88 [0.67-1.16],0.366529554242466,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.13 [0.87-1.46],0.366998149233449,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CSTB,Cystatin-B,Inverse variance weighted,28,1.01 [0.99-1.04],0.367521803322326,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.94 [0.81-1.08],0.368074154195494,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,3,1.05 [0.95-1.16],0.369482804250883,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.9 [0.71-1.14],0.370275907080652,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C7,Complement component C7,Inverse variance weighted,38,1.01 [0.99-1.03],0.37139957908772,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.99 [0.96-1.02],0.371634911944732,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,11,0.98 [0.93-1.03],0.372903941566247,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,0.95 [0.86-1.06],0.375935320018565,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.97 [0.91-1.04],0.377450848485451,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.99 [0.97-1.01],0.379000327180042,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.06 [0.93-1.22],0.37930688741965,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,1.02 [0.97-1.07],0.379315774680741,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DPT,Dermatopontin,Inverse variance weighted,21,0.99 [0.96-1.02],0.379703231698783,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLUL1,Clusterin-like protein 1,Inverse variance weighted,18,0.99 [0.96-1.01],0.380715280087521,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK6,Kallikrein-6,Inverse variance weighted,4,0.97 [0.92-1.03],0.381126225584243,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.98 [0.95-1.02],0.381339569605366,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,Wald ratio,1,1.02 [0.97-1.08],0.383055027062152,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,19,1.01 [0.99-1.02],0.383794588456667,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,26,0.99 [0.98-1.01],0.383935284772368,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACY1,Aminoacylase-1,Inverse variance weighted,4,0.96 [0.88-1.05],0.384589464465619,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Inverse variance weighted,44,0.99 [0.98-1.01],0.384742077320185,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.01 [0.99-1.03],0.385014044097143,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL4,C-C motif chemokine 4,Inverse variance weighted,18,1.02 [0.98-1.05],0.38512667962201,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,2,0.95 [0.85-1.06],0.3869170875003,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MVK,Mevalonate kinase,Inverse variance weighted,2,0.94 [0.81-1.09],0.38977162421789,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.02 [0.97-1.08],0.392263375949088,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.01 [0.99-1.03],0.392288781313714,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD209,CD209 antigen,Inverse variance weighted,15,1.02 [0.97-1.07],0.393412031129337,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.97 [0.9-1.04],0.396356759702132,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,1.04 [0.95-1.14],0.398347137935808,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.97 [0.9-1.04],0.401146643172243,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLB1,"Phospholipase B1, membrane-associated",Inverse variance weighted,33,0.99 [0.97-1.01],0.403207674448196,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGSF9,Protein turtle homolog A,Inverse variance weighted,10,0.98 [0.94-1.03],0.406119632811263,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.02 [0.98-1.06],0.410374912534358,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CALB1,Calbindin,Inverse variance weighted,2,1.06 [0.92-1.22],0.410799713417748,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLTP,Phospholipid transfer protein,Inverse variance weighted,19,0.99 [0.96-1.02],0.413187307017428,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ALCAM,CD166 antigen,Inverse variance weighted,6,0.96 [0.86-1.06],0.414106923696153,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.96 [0.86-1.07],0.414415940807816,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.98 [0.94-1.03],0.415222294145635,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,1.1 [0.87-1.4],0.41795214526919,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ELN,Elastin,Inverse variance weighted,2,1.17 [0.8-1.71],0.418539444898424,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.93 [0.78-1.11],0.421686457080093,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.98 [0.92-1.04],0.422289980024869,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,STAB2,Stabilin-2,Inverse variance weighted,20,1.01 [0.98-1.04],0.423667008380534,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.05 [0.93-1.18],0.424540150716432,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,1.11 [0.85-1.45],0.42629018123931,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,11,1.02 [0.98-1.05],0.428319705710675,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,25,1.01 [0.98-1.05],0.429467797222765,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.05 [0.93-1.19],0.42968432074755,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CALB2,Calretinin,Wald ratio,1,0.92 [0.76-1.13],0.429893467389396,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,31,0.99 [0.96-1.02],0.434432057458105,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MFGE8,Lactadherin,Inverse variance weighted,11,1.02 [0.97-1.07],0.434878475883029,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,0.99 [0.97-1.01],0.436666633345615,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPP1,Osteopontin,Inverse variance weighted,8,1.03 [0.95-1.12],0.437366482780349,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PALM2,Paralemmin-2,Inverse variance weighted,8,1.02 [0.96-1.09],0.437737722396287,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.01 [0.98-1.05],0.438490439821024,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.99-1.03],0.441473216795689,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.99 [0.95-1.02],0.441664361882482,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.95 [0.83-1.08],0.44190943750347,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LPO,Lactoperoxidase,Inverse variance weighted,4,0.99 [0.95-1.02],0.444156086830393,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.01 [0.99-1.03],0.446431082028781,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.97 [0.89-1.05],0.44806687964174,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,1.08 [0.89-1.31],0.449789596618487,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.91 [0.7-1.17],0.450587464870557,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1.02 [0.97-1.06],0.451005562001385,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSL,Cathepsin L1,Wald ratio,1,1.11 [0.85-1.44],0.451732089410153,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.98 [0.93-1.04],0.452997181221426,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ARSB,Arylsulfatase B,Inverse variance weighted,12,1.01 [0.98-1.05],0.453058671686982,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.02 [0.97-1.07],0.456109308406218,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGT,Angiotensinogen,Inverse variance weighted,14,1.01 [0.98-1.05],0.456555309831231,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Wald ratio,1,0.91 [0.72-1.16],0.458127851099778,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CST6,Cystatin-M,Inverse variance weighted,2,1.04 [0.93-1.17],0.460039694960455,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.09 [0.87-1.36],0.460501697898051,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,1.01 [0.98-1.05],0.46427385170632,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLMAP,Sarcolemmal membrane-associated protein,Inverse variance weighted,2,0.95 [0.81-1.1],0.46634151715449,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.97 [0.9-1.05],0.466363283010787,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.01 [0.99-1.03],0.467257070274211,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,11,1.01 [0.98-1.05],0.468460128571557,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.98 [0.93-1.03],0.470682829852701,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGMN,Legumain,Inverse variance weighted,12,0.99 [0.95-1.02],0.47145292090908,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,0.99 [0.95-1.03],0.472528836795309,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.01 [0.99-1.03],0.472821850775403,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOD,Apolipoprotein D,Inverse variance weighted,7,0.99 [0.95-1.02],0.473139263707123,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HPSE,Heparanase,Wald ratio,1,1.02 [0.97-1.06],0.476619573462142,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,0.98 [0.91-1.04],0.476629770016487,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.01 [0.99-1.03],0.477753003188679,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,1.06 [0.9-1.26],0.478425460264131,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.06 [0.9-1.26],0.478645824950192,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD46,Membrane cofactor protein,Wald ratio,1,0.95 [0.83-1.09],0.479034381158257,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.1 [0.84-1.43],0.479472313401333,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,1.01 [0.98-1.04],0.479632130727612,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MATN2,Matrilin-2,Inverse variance weighted,18,1.01 [0.98-1.05],0.481049107638232,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.06 [0.9-1.26],0.482032866419965,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCG3,Secretogranin-3,Inverse variance weighted,32,1.01 [0.99-1.03],0.48255744569238,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.99 [0.97-1.02],0.482934831291816,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOF,Apolipoprotein F,Inverse variance weighted,3,0.97 [0.91-1.05],0.483907617680293,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.98 [0.93-1.04],0.486740910943958,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.02 [0.97-1.07],0.487300373991899,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.96 [0.87-1.07],0.490091945171129,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.01 [0.98-1.05],0.491316598832728,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAT,Linker for activation of T-cells family member 1,Wald ratio,1,1.11 [0.83-1.48],0.492375771419729,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.92 [0.73-1.17],0.493027571554665,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.01 [0.98-1.03],0.493094998238842,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,1.06 [0.9-1.25],0.494797342322146,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AMN,Protein amnionless,Inverse variance weighted,39,0.99 [0.97-1.02],0.496725824198298,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.03 [0.95-1.11],0.496992137672574,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL15,Interleukin-15,Wald ratio,1,1.47 [0.48-4.46],0.497174372298604,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,Inverse variance weighted,3,1.03 [0.94-1.13],0.500102389578608,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.99 [0.96-1.02],0.500658108338482,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDA,Cytidine deaminase,Inverse variance weighted,20,1.01 [0.98-1.04],0.502394830511258,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,0.94 [0.79-1.12],0.504667006795451,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.99 [0.95-1.03],0.505949302552857,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.02 [0.97-1.06],0.507981622987016,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,6,1.02 [0.97-1.07],0.509866678105047,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.02 [0.95-1.1],0.511198062160879,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VWC2,Brorin,Inverse variance weighted,22,1.01 [0.98-1.05],0.511298009432602,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1.02 [0.96-1.08],0.511539395781061,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,4,1.04 [0.93-1.15],0.512031387343925,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LPL,Lipoprotein lipase,Inverse variance weighted,14,0.99 [0.95-1.02],0.513168090227136,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLIN3,Perilipin-3,Wald ratio,1,1.06 [0.89-1.25],0.513549547145098,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,0.99 [0.96-1.02],0.514382207113959,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.91 [0.69-1.21],0.514953173954392,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,1.01 [0.99-1.03],0.515800230544098,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD48,CD48 antigen,Inverse variance weighted,18,1.01 [0.99-1.03],0.51609913452851,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1.07 [0.87-1.32],0.517098675693205,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,43,1 [0.99-1.02],0.518036329168336,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,1.02 [0.97-1.07],0.518581652899945,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL16,Pro-interleukin-16,Inverse variance weighted,16,1.01 [0.98-1.04],0.520612025498405,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,1.02 [0.96-1.08],0.521253499074575,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,F3,Tissue factor,Inverse variance weighted,11,0.99 [0.94-1.03],0.522334400575086,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS9,Galectin-9,Inverse variance weighted,26,1.01 [0.98-1.04],0.522511570423021,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FUOM,Fucose mutarotase,Inverse variance weighted,3,1.04 [0.92-1.19],0.524090022776326,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PKD2,Polycystin-2,Inverse variance weighted,3,1.07 [0.87-1.31],0.524615322365548,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TPR,Nucleoprotein TPR,Wald ratio,1,1.06 [0.88-1.28],0.524819289402723,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.02 [0.96-1.09],0.526571059391605,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.01 [0.98-1.03],0.528362896668437,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.01 [0.98-1.04],0.529546686247476,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.01 [0.98-1.05],0.529954658572074,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.02 [0.96-1.07],0.531355968098108,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.98 [0.93-1.04],0.531866596281941,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.02 [0.97-1.07],0.531958763641279,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.99 [0.95-1.03],0.535830793018419,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,0.93 [0.74-1.17],0.536892721058922,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,0.95 [0.82-1.11],0.538278812594977,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CREG1,Protein CREG1,Inverse variance weighted,3,0.97 [0.88-1.07],0.539264174782731,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.99 [0.96-1.02],0.541780234392031,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,47,1.01 [0.99-1.03],0.543251855336575,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.98 [0.93-1.04],0.54359999499953,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BPIFA2,BPI fold-containing family A member 2,Inverse variance weighted,5,0.98 [0.92-1.04],0.546011159554432,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.99 [0.94-1.03],0.546556329920568,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1.02 [0.96-1.08],0.548974588893543,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LCN15,Lipocalin-15,Inverse variance weighted,20,0.99 [0.97-1.02],0.549910273543074,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.99 [0.95-1.03],0.550133487221096,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.99 [0.96-1.02],0.552133426672009,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.02 [0.95-1.1],0.552148165553972,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,7,0.98 [0.9-1.06],0.553464081601802,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.94 [0.78-1.14],0.554111879917424,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,1.01 [0.98-1.03],0.560888491756285,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPON2,Spondin-2,Inverse variance weighted,4,1.02 [0.96-1.07],0.561922489723589,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.98 [0.9-1.06],0.562998207466602,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PKD1,Polycystin-1,Inverse variance weighted,12,0.98 [0.93-1.04],0.563858197275203,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.99 [0.95-1.03],0.564100764602294,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,0.98 [0.92-1.05],0.568020321723271,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.03 [0.94-1.12],0.569760438815211,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL5,C-C motif chemokine 5,Inverse variance weighted,2,1.06 [0.86-1.31],0.576841668354473,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.05 [0.89-1.22],0.576911231551059,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,1.03 [0.92-1.15],0.577256128982839,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANPEP,Aminopeptidase N,Inverse variance weighted,23,1.01 [0.98-1.04],0.577864988915967,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.03 [0.93-1.13],0.580544550183463,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCN4,CCN family member 4,Inverse variance weighted,27,0.99 [0.97-1.02],0.581224476802674,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,9,0.97 [0.86-1.09],0.581566589494829,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1 [0.99-1.02],0.582330389199476,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1 [0.98-1.01],0.587858735069918,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.01 [0.97-1.06],0.589094894144471,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NFASC,Neurofascin,Inverse variance weighted,15,0.99 [0.96-1.02],0.590025250807827,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.98 [0.92-1.05],0.590447447890992,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Wald ratio,1,1.03 [0.93-1.14],0.590980262176766,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK4,Kallikrein-4,Inverse variance weighted,17,0.99 [0.96-1.02],0.594528872898209,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCAN,Brevican core protein,Inverse variance weighted,3,0.98 [0.92-1.05],0.599767002273297,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GUCA2A,Guanylin,Inverse variance weighted,9,0.98 [0.93-1.04],0.600232191101496,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP3,Stromelysin-1,Inverse variance weighted,34,1.01 [0.97-1.05],0.600697602991681,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.94 [0.75-1.18],0.601883855652761,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.99 [0.94-1.04],0.602845885039231,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.99 [0.97-1.02],0.602960408379333,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.03 [0.93-1.14],0.60480326885423,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ARSA,Arylsulfatase A,Inverse variance weighted,16,1.01 [0.99-1.02],0.608804921109771,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,19,0.99 [0.96-1.02],0.610867454745951,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.01 [0.96-1.07],0.611697854913178,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,XCL1,Lymphotactin,Inverse variance weighted,31,1.01 [0.99-1.03],0.612417157105208,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.97 [0.87-1.08],0.612742265662793,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.99 [0.97-1.02],0.612772078518139,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RETN,Resistin,Inverse variance weighted,9,1.01 [0.98-1.03],0.613199593933003,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.99 [0.97-1.02],0.613636152283849,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DRAXIN,Draxin,Inverse variance weighted,13,0.99 [0.94-1.04],0.618805440856685,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,1.02 [0.94-1.11],0.619678511756343,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,4,1.02 [0.95-1.09],0.620581712062023,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,0.99 [0.96-1.03],0.623552187616813,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PALM,Paralemmin-1,Inverse variance weighted,6,0.98 [0.92-1.05],0.624656451724307,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MB,Myoglobin,Wald ratio,1,0.92 [0.67-1.28],0.626714643945532,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RSPO3,R-spondin-3,Inverse variance weighted,6,0.97 [0.84-1.11],0.627433462732177,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.01 [0.97-1.05],0.62857610701173,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SORT1,Sortilin,Inverse variance weighted,3,1.03 [0.91-1.17],0.632354425863112,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.02 [0.95-1.08],0.63254229036553,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.99 [0.95-1.03],0.637316012198093,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFNL1,Interferon lambda-1,Wald ratio,1,1.07 [0.81-1.41],0.63757254145574,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,F2R,Proteinase-activated receptor 1,Inverse variance weighted,2,0.96 [0.81-1.14],0.638390326540035,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1 [0.98-1.01],0.639273894416159,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LSP1,Lymphocyte-specific protein 1,Inverse variance weighted,6,1.06 [0.83-1.37],0.639809313898439,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,0.98 [0.92-1.06],0.642929390678908,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.99 [0.95-1.04],0.644253449484557,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PVR,Poliovirus receptor,Inverse variance weighted,27,1 [0.99-1.02],0.644288958557555,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPR15L,Protein GPR15L,Inverse variance weighted,9,1.01 [0.97-1.05],0.644917080377394,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,17,0.99 [0.96-1.02],0.645608677209646,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.05 [0.86-1.28],0.646633017610811,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NRP2,Neuropilin-2,Inverse variance weighted,11,0.99 [0.95-1.03],0.647365057315014,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TF,Serotransferrin,Inverse variance weighted,11,0.99 [0.96-1.03],0.648638227143097,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.02 [0.95-1.08],0.651073850226553,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,1.03 [0.9-1.19],0.656018834605333,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.01 [0.96-1.06],0.656607635669319,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.99 [0.96-1.03],0.663346323353817,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.99 [0.93-1.04],0.664663638889037,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPINB8,Serpin B8,Inverse variance weighted,28,1 [0.98-1.01],0.668267958600447,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.99 [0.95-1.03],0.668429318280528,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.02 [0.93-1.13],0.669568836424399,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,STX8,Syntaxin-8,Wald ratio,1,1.03 [0.89-1.19],0.670964660144091,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,STC2,Stanniocalcin-2,Inverse variance weighted,3,1.05 [0.84-1.31],0.679326157498083,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,1.08 [0.75-1.56],0.679937984330245,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.02 [0.94-1.1],0.681067545064638,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC3B,Tetranectin,Inverse variance weighted,7,1.01 [0.96-1.06],0.684284372576776,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.99 [0.95-1.03],0.684546006592965,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OCLN,Occludin,Inverse variance weighted,2,0.98 [0.89-1.08],0.686177820438861,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.98 [0.86-1.1],0.686470045689413,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.99 [0.94-1.05],0.6898917541176,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1 [0.98-1.03],0.690773745843715,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.99 [0.95-1.04],0.691584914288587,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,0.99 [0.92-1.06],0.696715591567289,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,5,0.98 [0.88-1.09],0.699412702301048,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.02 [0.92-1.14],0.70073678013214,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MYOM3,Myomesin-3,Wald ratio,1,1.03 [0.88-1.21],0.701486844552035,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD83,CD83 antigen,Inverse variance weighted,5,1.01 [0.95-1.08],0.704524406378146,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD248,Endosialin,Inverse variance weighted,2,0.95 [0.74-1.22],0.704925108954386,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OGN,Mimecan,Inverse variance weighted,30,1 [0.97-1.02],0.705835694705196,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.03 [0.87-1.23],0.707361688611889,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.99 [0.96-1.03],0.710487804880895,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1 [0.98-1.01],0.712955652118717,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CFH,Complement factor H,Inverse variance weighted,19,0.99 [0.96-1.03],0.713279399537495,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH5,Cadherin-5,Inverse variance weighted,3,1.03 [0.88-1.21],0.713690647675412,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1 [0.97-1.02],0.71692853326627,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,0.99 [0.94-1.04],0.716984067301618,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TCOF1,Treacle protein,Wald ratio,1,0.96 [0.75-1.21],0.717283481774687,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CES1,Liver carboxylesterase 1,Inverse variance weighted,15,0.99 [0.96-1.03],0.717936721476474,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1 [0.98-1.03],0.718207470681853,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL1A1,Collagen alpha-1(I) chain,Wald ratio,1,0.95 [0.73-1.24],0.718383560869976,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.92 [0.57-1.47],0.719272785120143,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.99 [0.91-1.06],0.720068643381034,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.99 [0.94-1.04],0.72277941052252,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.01 [0.94-1.1],0.723692218554728,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSF,Cathepsin F,Inverse variance weighted,10,1.01 [0.94-1.1],0.725382425704559,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TCN2,Transcobalamin-2,Inverse variance weighted,34,1 [0.97-1.02],0.72731468642999,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRYBB2,Beta-crystallin B2,Wald ratio,1,1.03 [0.86-1.23],0.727449046936608,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.01 [0.96-1.06],0.731757890105346,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,14,0.99 [0.96-1.03],0.732767816265139,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.99 [0.94-1.04],0.732968279843521,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.06 [0.76-1.47],0.737642171345368,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.03 [0.87-1.22],0.737780147100356,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Inverse variance weighted,12,1.01 [0.97-1.04],0.73875840103902,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",Wald ratio,1,0.96 [0.75-1.23],0.742519232408895,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.02 [0.92-1.13],0.74364393901553,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTGES2,Prostaglandin E synthase 2,Wald ratio,1,0.97 [0.79-1.19],0.744960153166616,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,1 [0.98-1.03],0.745324251288083,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1 [0.98-1.03],0.745940613473193,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,1.03 [0.88-1.2],0.745982685140213,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,0.99 [0.95-1.04],0.746799803664233,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.02 [0.93-1.11],0.74897309446235,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.98 [0.88-1.09],0.750104970494561,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPC5,Glypican-5,Inverse variance weighted,33,1 [0.97-1.02],0.750298874393596,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,1.01 [0.96-1.07],0.750805053668097,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1 [0.98-1.02],0.750922700968617,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,12,0.99 [0.95-1.04],0.752250408470447,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,13,0.99 [0.96-1.03],0.752336198415651,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.01 [0.96-1.06],0.753093826753687,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGRP,Agouti-related protein,Inverse variance weighted,3,0.98 [0.86-1.11],0.755005362476287,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHAD,Chondroadherin,Inverse variance weighted,3,1.01 [0.97-1.04],0.755529300433688,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,THOP1,Thimet oligopeptidase,Inverse variance weighted,5,1.01 [0.96-1.06],0.759803443645948,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,QDPR,Dihydropteridine reductase,Inverse variance weighted,8,1.01 [0.94-1.08],0.76089909818532,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD276,CD276 antigen,Inverse variance weighted,20,1 [0.98-1.03],0.763949695605453,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.01 [0.92-1.12],0.768042630239848,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.97 [0.79-1.2],0.769377106179956,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,1.01 [0.97-1.04],0.77010693325121,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPB2,Carboxypeptidase B2,Inverse variance weighted,27,1 [0.97-1.04],0.770823415640364,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.98 [0.84-1.14],0.772925267957298,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.02 [0.87-1.2],0.773101030286897,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.99 [0.9-1.08],0.773109357982069,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SELENOP,Selenoprotein P,Inverse variance weighted,2,1.02 [0.92-1.13],0.773726274427972,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHGB,Secretogranin-1,Inverse variance weighted,27,1 [0.97-1.02],0.774627633367682,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ELOA,Elongin-A,Inverse variance weighted,2,0.98 [0.87-1.11],0.776780341040513,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,Inverse variance weighted,33,1 [0.99-1.01],0.776794370536917,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.01 [0.97-1.05],0.781759015655459,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANXA10,Annexin A10,Wald ratio,1,1.03 [0.81-1.31],0.781860574999605,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANXA5,Annexin A5,Inverse variance weighted,2,0.98 [0.88-1.1],0.783119157214337,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.99 [0.95-1.04],0.784852092382006,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TTR,Transthyretin,Inverse variance weighted,3,1.02 [0.88-1.18],0.785877919031158,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,S100P,Protein S100-P,Inverse variance weighted,2,0.98 [0.83-1.15],0.788762543634172,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,19,1 [0.98-1.02],0.789385690597623,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.99 [0.94-1.05],0.790742584433107,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1 [0.97-1.03],0.791292204919589,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.98 [0.86-1.12],0.793658640341028,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.01 [0.95-1.07],0.797303622772489,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.02 [0.86-1.22],0.800893291145202,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.06 [0.68-1.63],0.802712254944166,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1 [0.97-1.02],0.803935191580434,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.04 [0.75-1.46],0.804462163137867,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1 [0.96-1.03],0.804722790018338,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MYBPC2,"Myosin-binding protein C, fast-type",Wald ratio,1,0.96 [0.7-1.32],0.807574633709126,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.98 [0.8-1.2],0.809433113375068,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,1 [0.98-1.03],0.811711709521009,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,1.02 [0.85-1.22],0.812965255737041,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCL2,Apoptosis regulator Bcl-2,Inverse variance weighted,2,0.98 [0.8-1.19],0.815600071629843,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.99 [0.89-1.09],0.817270359850954,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.98 [0.82-1.17],0.817790265101974,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1 [0.98-1.01],0.818158162580767,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.01 [0.94-1.09],0.822690678846418,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.01 [0.95-1.07],0.822927841328551,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1 [0.97-1.04],0.825380893121075,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,31,1 [0.97-1.02],0.82561274115002,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MDK,Midkine,Inverse variance weighted,4,1.01 [0.93-1.09],0.825654554725232,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NECTIN2,Nectin-2,Inverse variance weighted,5,0.99 [0.92-1.07],0.826363316940399,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,0.99 [0.86-1.13],0.829543187200626,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PI16,Peptidase inhibitor 16,Inverse variance weighted,15,1 [0.97-1.04],0.83139134301151,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1 [0.97-1.03],0.832051888976713,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,THBD,Thrombomodulin,Inverse variance weighted,5,0.99 [0.91-1.08],0.835726941588928,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1 [0.98-1.02],0.836092994090884,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.99 [0.88-1.11],0.836578503776549,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS3,Galectin-3,Inverse variance weighted,25,1 [0.97-1.02],0.836861072269397,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.01 [0.95-1.07],0.836910154346738,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.99 [0.9-1.09],0.838508534552447,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.02 [0.85-1.22],0.838953698398097,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1 [0.97-1.03],0.839942711411344,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1 [0.97-1.04],0.842030944663581,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1 [0.96-1.05],0.844341184218156,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1 [0.96-1.05],0.844789284790876,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.02 [0.86-1.21],0.845110070250031,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MILR1,Allergin-1,Inverse variance weighted,33,1 [0.98-1.02],0.847779569924659,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,0.98 [0.84-1.15],0.848049767688051,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK11,Kallikrein-11,Inverse variance weighted,6,1 [0.97-1.04],0.849197838946911,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1 [0.96-1.05],0.849568359952648,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.99 [0.92-1.07],0.852719531557322,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.95-1.04],0.854038157134654,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,1 [0.98-1.03],0.855151039954209,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSC,Dipeptidyl peptidase 1,Inverse variance weighted,28,1 [0.98-1.02],0.85707042185944,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.01 [0.93-1.09],0.857731303642535,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,1 [0.96-1.03],0.859210270812773,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RBP2,Retinol-binding protein 2,Wald ratio,1,0.98 [0.8-1.2],0.860340836915093,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,17,1 [0.96-1.05],0.86036476975671,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRELP,Prolargin,Inverse variance weighted,9,1 [0.95-1.04],0.860834318792691,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.02 [0.84-1.23],0.863054832440755,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1 [0.96-1.05],0.865596458247738,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1 [0.96-1.03],0.870151365876666,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1 [0.95-1.06],0.871694426166298,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCN5,CCN family member 5,Inverse variance weighted,8,0.99 [0.9-1.09],0.872187929225819,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPPC,C-type natriuretic peptide,Wald ratio,1,0.98 [0.73-1.31],0.872652012407616,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1 [0.96-1.04],0.873195128653964,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.99 [0.87-1.13],0.873828110510213,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCAMP3,Secretory carrier-associated membrane protein 3,Wald ratio,1,0.99 [0.84-1.16],0.873984193148033,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP7,Matrilysin,Inverse variance weighted,13,1 [0.96-1.05],0.875220979665602,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1 [0.95-1.05],0.876084350475765,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1 [0.99-1.01],0.876193247178458,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.99 [0.88-1.11],0.878083396396247,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.01 [0.94-1.08],0.878930851988986,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SEPTIN8,Septin-8,Inverse variance weighted,2,0.99 [0.91-1.08],0.879577630137977,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1 [0.98-1.02],0.880397120351057,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRTN3,Myeloblastin,Inverse variance weighted,21,1 [0.97-1.03],0.881141141824385,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1 [0.99-1.01],0.88192413024418,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GBP1,Guanylate-binding protein 1,Inverse variance weighted,10,1 [0.96-1.04],0.883985647604382,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.98 [0.72-1.33],0.884131676743726,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SDC1,Syndecan-1,Inverse variance weighted,2,1.01 [0.88-1.17],0.884949577697582,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,1 [0.96-1.05],0.885801219372094,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FCN1,Ficolin-1,Inverse variance weighted,28,1 [0.98-1.03],0.888459297800396,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,9,1 [0.96-1.04],0.888488316754128,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1 [0.96-1.05],0.88909004188188,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ZBP1,Z-DNA-binding protein 1,Inverse variance weighted,6,1 [0.94-1.07],0.890390726154093,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,1 [0.96-1.03],0.890654800651908,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",Wald ratio,1,0.99 [0.81-1.2],0.89235178533296,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.99 [0.84-1.17],0.893103424976311,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NADK,NAD kinase,Inverse variance weighted,4,1.01 [0.82-1.26],0.893695727194314,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1 [0.93-1.06],0.894194595871117,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1 [0.95-1.04],0.897299337364194,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,1.01 [0.9-1.13],0.898077379236497,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.99 [0.89-1.11],0.901390003017899,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1 [0.99-1.02],0.902598565003677,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TSPAN8,Tetraspanin-8,Inverse variance weighted,25,1 [0.97-1.03],0.90342900925623,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1 [0.96-1.03],0.90442569082741,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.02 [0.77-1.35],0.906830839589125,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ENAH,Protein enabled homolog,Inverse variance weighted,2,1.01 [0.9-1.12],0.90910750551796,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.98 [0.73-1.32],0.910306655008887,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGFBP3,Fibroblast growth factor-binding protein 3,Inverse variance weighted,19,1 [0.97-1.03],0.91435044470529,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NRP1,Neuropilin-1,Inverse variance weighted,12,1 [0.97-1.03],0.915408937957967,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH6,Cadherin-6,Inverse variance weighted,29,1 [0.98-1.02],0.920903924399726,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1 [0.97-1.03],0.920999696393538,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1 [0.96-1.04],0.921032888455941,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1 [0.93-1.08],0.922886029868352,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1 [0.9-1.1],0.924501943333933,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH17,Cadherin-17,Inverse variance weighted,14,1 [0.97-1.04],0.924775311575766,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1 [0.96-1.05],0.924893013305288,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1 [0.95-1.05],0.924899049210286,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGA,Fibrinogen alpha chain,Inverse variance weighted,7,1 [0.93-1.08],0.9298177349662,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,8,1 [0.94-1.06],0.929913274779475,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GUSB,Beta-glucuronidase,Inverse variance weighted,4,1 [0.92-1.09],0.930768812975586,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH15,Cadherin-15,Inverse variance weighted,18,1 [0.97-1.03],0.931707867241423,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1 [0.97-1.03],0.931903251069437,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TYMP,Thymidine phosphorylase,Inverse variance weighted,4,1 [0.95-1.06],0.932005730499142,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1 [0.96-1.04],0.932242685010442,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.99 [0.82-1.2],0.936542609433398,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPON1,Spondin-1,Inverse variance weighted,21,1 [0.96-1.05],0.936711039689062,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH1,Cadherin-1,Wald ratio,1,1.01 [0.78-1.31],0.94451751903199,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1 [0.94-1.06],0.94909569501736,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,1 [0.97-1.03],0.949620952130874,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL18,Interleukin-18,Inverse variance weighted,16,1 [0.91-1.1],0.952482418005575,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1 [0.96-1.04],0.953408387647674,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.01 [0.76-1.34],0.954650834919858,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1 [0.84-1.17],0.956600700441025,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TCTN3,Tectonic-3,Inverse variance weighted,33,1 [0.98-1.02],0.956615301137431,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1 [0.95-1.05],0.957646202465965,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,1 [0.91-1.09],0.957704848664463,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,16,1 [0.97-1.03],0.959174536253059,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1 [0.98-1.03],0.963578539836229,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,1 [0.98-1.02],0.965436524097401,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1 [0.8-1.26],0.967679338311053,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,1 [0.79-1.25],0.967848900142203,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ERBB3,Receptor tyrosine-protein kinase erbB-3,Inverse variance weighted,7,1 [0.93-1.07],0.969843288149926,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,6,1 [0.96-1.04],0.971433898534049,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1 [0.9-1.1],0.97172202193284,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS8,Galectin-8,Inverse variance weighted,7,1 [0.96-1.04],0.971934257167762,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNN,Tenascin-N,Inverse variance weighted,44,1 [0.98-1.02],0.972822482270327,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,19,1 [0.97-1.03],0.973533052851791,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS1,Galectin-1,Inverse variance weighted,6,1 [0.93-1.07],0.973682496854137,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FIS1,Mitochondrial fission 1 protein,Wald ratio,1,1 [0.93-1.08],0.974013167051693,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1 [0.94-1.07],0.97519318387036,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Inverse variance weighted,3,1 [0.94-1.07],0.97720390992798,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1 [0.9-1.11],0.978075697136659,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1 [0.95-1.05],0.978600513798318,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NOMO1,Nodal modulator 1,Inverse variance weighted,2,1 [0.88-1.14],0.979575017087355,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1 [0.97-1.03],0.981374052160733,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1 [0.87-1.15],0.981871263650191,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1 [0.95-1.05],0.982036840592551,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL19,Interleukin-19,Inverse variance weighted,11,1 [0.95-1.05],0.982783111638497,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1 [0.94-1.06],0.983573523379599,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1 [0.97-1.03],0.986317395666042,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLITRK1,SLIT and NTRK-like protein 1,Wald ratio,1,1 [0.89-1.12],0.986620135023591,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1 [0.98-1.02],0.987276440014547,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1 [0.95-1.05],0.988507664703307,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRSS2,Trypsin-2,Inverse variance weighted,3,1 [0.8-1.25],0.988773202805898,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1 [0.9-1.11],0.989495491688891,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GSN,Gelsolin,Inverse variance weighted,5,1 [0.87-1.15],0.990067327589406,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COLEC12,Collectin-12,Inverse variance weighted,11,1 [0.95-1.05],0.990233261870263,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSZ,Cathepsin Z,Inverse variance weighted,3,1 [0.89-1.12],0.992291860758417,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1 [0.9-1.12],0.992330496700169,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1 [0.93-1.07],0.993255926900873,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1 [0.87-1.15],0.993562689692972,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRH,Corticoliberin,Inverse variance weighted,11,1 [0.96-1.04],0.993636635931278,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ATOX1,Copper transport protein ATOX1,Wald ratio,1,1 [0.84-1.19],0.993786151618419,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,F11R,Junctional adhesion molecule A,Wald ratio,1,1 [0.82-1.22],0.994973233389638,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPD1,Glycerol-3-phosphate dehydrogenase,Wald ratio,1,1 [0.82-1.21],0.996855171021218,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1 [0.92-1.09],0.999302544606353,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,1 [0.98-1.02],0.999485623790327,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,2.05 [1.58-2.65],4.68435294482525e-08,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.43 [1.25-1.63],2.2068563460547e-07,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.06 [1.03-1.09],1.60129902787188e-05,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.12 [1.06-1.18],2.66009343716453e-05,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSB,Cathepsin B,Inverse variance weighted,28,0.88 [0.83-0.94],9.07133566748353e-05,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,11,1.15 [1.06-1.23],0.000307893375645546,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,1.17 [1.07-1.28],0.000367427824574434,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.88 [0.81-0.94],0.000446883683993805,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DDT,D-dopachrome decarboxylase,Wald ratio,1,1.66 [1.25-2.21],0.000487790157452525,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL8,Interleukin-8,Inverse variance weighted,8,1.13 [1.05-1.21],0.000583935152766994,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.67 [1.24-2.24],0.000742530251431039,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFNGR2,Interferon gamma receptor 2,Inverse variance weighted,34,1.04 [1.02-1.06],0.000778873656271331,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.72 [0.58-0.88],0.00139265532603925,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VWC2,Brorin,Inverse variance weighted,12,1.25 [1.09-1.43],0.00140873613829237,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.64 [1.21-2.22],0.00141498526408593,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.27 [1.09-1.48],0.00175193158673486,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL4,C-C motif chemokine 4,Inverse variance weighted,37,1.04 [1.02-1.07],0.00229539423272177,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.13 [1.05-1.23],0.00254262625865161,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.51 [1.15-1.97],0.00274506469123953,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,1.03 [1.01-1.04],0.00334800594053204,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.45 [1.13-1.85],0.00346172186556805,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.17 [1.05-1.31],0.00372455880295185,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ARSA,Arylsulfatase A,Inverse variance weighted,7,1.07 [1.02-1.12],0.00405969597738873,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACY1,Aminoacylase-1,Inverse variance weighted,6,1.19 [1.06-1.35],0.00410027394784547,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CST3,Cystatin-C,Inverse variance weighted,3,1.27 [1.08-1.5],0.00413274563957685,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD160,CD160 antigen,Inverse variance weighted,24,0.93 [0.89-0.98],0.00526944864437013,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.12 [1.03-1.22],0.00534123821272572,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,33,1.03 [1.01-1.06],0.00539702840343895,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.95 [0.92-0.99],0.00553175708271763,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSF,Cathepsin F,Inverse variance weighted,27,1.07 [1.02-1.12],0.00562064945190574,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.3 [1.08-1.56],0.00572480297526206,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,6,1.19 [1.05-1.34],0.0068424313513281,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.12 [1.03-1.22],0.00695204674368743,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSO,Cathepsin O,Inverse variance weighted,19,1.08 [1.02-1.14],0.00796373710692953,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,0.87 [0.78-0.96],0.00871447634862417,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DBI,Acyl-CoA-binding protein,Wald ratio,1,0.8 [0.68-0.95],0.00882925718161224,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C7,Complement component C7,Inverse variance weighted,26,1.04 [1.01-1.07],0.00888598113601033,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,1.36 [1.08-1.71],0.00988868055258262,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRL,Prolactin,Inverse variance weighted,7,1.12 [1.03-1.23],0.00998222499738124,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.74 [0.59-0.93],0.0103032805734315,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.35 [1.07-1.7],0.0108879838216636,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GSTA1,Glutathione S-transferase A1,Wald ratio,1,1.46 [1.09-1.95],0.0109802133315735,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PPL,Periplakin,Inverse variance weighted,2,1.23 [1.05-1.44],0.0110408610174134,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTP4A3,Protein tyrosine phosphatase type IVA 3,Inverse variance weighted,6,1.07 [1.01-1.12],0.0121420650899565,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGA5,Integrin alpha-5,Inverse variance weighted,18,0.92 [0.85-0.98],0.0123379999121086,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.82 [0.7-0.96],0.0129124895679482,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.84 [0.73-0.96],0.0129145161040012,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,0.93 [0.89-0.99],0.0130863258905501,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MDK,Midkine,Inverse variance weighted,14,0.92 [0.87-0.98],0.0139151681372355,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.79 [0.65-0.96],0.0167945787839977,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP7,Matrilysin,Wald ratio,1,0.87 [0.78-0.98],0.0173275980648243,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.93 [0.88-0.99],0.018055668603888,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.09 [1.01-1.16],0.0182704922529956,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.95 [0.91-0.99],0.0191665802915772,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.88 [0.78-0.98],0.0201493621698013,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSC,Dipeptidyl peptidase 1,Inverse variance weighted,12,1.1 [1.01-1.19],0.0201716130710769,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,0.87 [0.77-0.98],0.0205125680230108,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCN1,CCN family member 1,Inverse variance weighted,6,1.17 [1.02-1.33],0.0206943844025775,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.66 [0.46-0.94],0.0214005821769715,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.95 [0.91-0.99],0.0229781256411158,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.23 [1.03-1.47],0.0230613148045941,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.24 [1.03-1.49],0.0232147387639614,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",Wald ratio,1,1.41 [1.05-1.91],0.0233033783694465,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TCN1,Transcobalamin-1,Inverse variance weighted,42,1.06 [1.01-1.11],0.0245669347323704,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,0.88 [0.78-0.98],0.0247481338590022,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.87 [0.77-0.98],0.0252889258820689,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.18 [1.02-1.37],0.025413052230763,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.93 [0.87-0.99],0.0256451979709069,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,3,1.24 [1.03-1.51],0.0261683661182217,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.96 [0.92-1],0.0268018543286561,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NT5E,5'-nucleotidase,Inverse variance weighted,45,1.03 [1-1.07],0.0274514973198141,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BRK1,Protein BRICK1,Inverse variance weighted,10,0.94 [0.89-0.99],0.0280344989525281,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLSTN3,Calsyntenin-3,Inverse variance weighted,7,1.33 [1.03-1.72],0.0286125975750546,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.2 [1.02-1.42],0.0287471934858151,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RSPO1,R-spondin-1,Inverse variance weighted,8,0.92 [0.86-0.99],0.0291487720653753,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.95 [0.9-0.99],0.0295408069418281,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,23,0.9 [0.82-0.99],0.0304091124488779,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCG2,Secretogranin-2,Inverse variance weighted,2,0.84 [0.73-0.98],0.0306771612084117,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANPEP,Aminopeptidase N,Inverse variance weighted,2,1.24 [1.02-1.5],0.031269026007034,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.22 [1.02-1.47],0.0313755310002288,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ASS1,Argininosuccinate synthase,Inverse variance weighted,2,0.83 [0.7-0.98],0.031933521557902,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAM3D,Protein FAM3D,Inverse variance weighted,38,0.97 [0.95-1],0.0325290427409142,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.06 [1-1.12],0.0326394627745812,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.85 [0.73-0.99],0.0329266084816424,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.9 [0.82-0.99],0.0332358145645143,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDA,Cytidine deaminase,Inverse variance weighted,14,0.92 [0.86-0.99],0.0333161899697077,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.22 [1.02-1.47],0.0335677628103102,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,0.98 [0.96-1],0.0336732123708892,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1RAP,Interleukin-1 receptor accessory protein,Inverse variance weighted,7,0.83 [0.7-0.99],0.0338452003543739,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.2 [1.01-1.42],0.0348274369086804,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGSF9,Protein turtle homolog A,Inverse variance weighted,2,1.21 [1.01-1.44],0.0351399813630312,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.17 [1.01-1.36],0.0375952541598904,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,S100A12,Protein S100-A12,Inverse variance weighted,4,0.86 [0.74-0.99],0.0377657058906535,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,8,1.07 [1-1.14],0.039138038186126,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.8 [0.65-0.99],0.0396393370559044,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,STAB2,Stabilin-2,Inverse variance weighted,14,1.1 [1-1.2],0.0407202194694956,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.84 [0.71-0.99],0.0408967613629425,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.88 [0.77-1],0.042144340933661,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.03 [1-1.05],0.0437219396079454,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH17,Cadherin-17,Inverse variance weighted,31,0.98 [0.95-1],0.0473468228107077,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCN3,CCN family member 3,Inverse variance weighted,17,1.04 [1-1.08],0.0474373370738226,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.64 [0.41-1],0.047809983958347,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOD,Apolipoprotein D,Inverse variance weighted,9,0.76 [0.59-1],0.048014488675101,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.38 [1-1.91],0.0483129387824959,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.27 [1-1.6],0.0492046252547793,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,POMC,Pro-opiomelanocortin,Inverse variance weighted,15,0.85 [0.73-1],0.0494315221396719,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PGA4,Pepsin A-4,Inverse variance weighted,7,0.91 [0.83-1],0.049616277394466,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.89 [0.8-1],0.0522162259754233,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,0.83 [0.69-1],0.0525790600397994,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.09 [1-1.19],0.0529139290219025,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1.02 [1-1.04],0.0533768852902324,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAT,Linker for activation of T-cells family member 1,Inverse variance weighted,2,0.83 [0.68-1],0.0537386666039395,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK6,Kallikrein-6,Inverse variance weighted,2,1.51 [0.99-2.31],0.0541858340371051,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.2 [1-1.45],0.0552934432234142,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.78 [0.6-1.01],0.0572216341011554,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.11 [1-1.24],0.0576346098090504,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SELE,E-selectin,Inverse variance weighted,20,0.97 [0.94-1],0.0578421096659136,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DSC2,Desmocollin-2,Inverse variance weighted,16,0.96 [0.92-1],0.0591414025229049,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,22,1.04 [1-1.08],0.0599087532601044,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.83 [0.69-1.01],0.06009565238543,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.09 [1-1.19],0.0605108978364502,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP3,Stromelysin-1,Inverse variance weighted,4,1.2 [0.99-1.46],0.0605809130303365,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DPT,Dermatopontin,Inverse variance weighted,4,1.15 [0.99-1.33],0.0612331711798219,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,0.96 [0.92-1],0.0622367894248475,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.04 [1-1.09],0.0624791971662982,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.08 [1-1.17],0.0624978046387978,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,1.04 [1-1.09],0.06285107361982,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.03 [1-1.06],0.0630003662220748,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MENT,Protein MENT,Inverse variance weighted,28,0.96 [0.92-1],0.064554841786262,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPI,Glucose-6-phosphate isomerase,Wald ratio,1,0.76 [0.57-1.02],0.0646066043121508,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.88 [0.76-1.01],0.0653156000274756,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.05 [1-1.11],0.0671538267156714,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.97-1],0.0673444195964179,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.03 [1-1.07],0.0676377987455294,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.13 [0.99-1.28],0.0678029445720002,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",Wald ratio,1,0.77 [0.58-1.02],0.0680977341393961,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ABL1,Tyrosine-protein kinase ABL1,Inverse variance weighted,3,1.12 [0.99-1.27],0.0682151355442772,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,1.23 [0.98-1.55],0.0684371150457375,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.2 [0.99-1.47],0.0685890990467044,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.13 [0.99-1.29],0.0687725152271653,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Inverse variance weighted,2,1.55 [0.96-2.49],0.0718429614473388,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPO,Erythropoietin,Inverse variance weighted,11,0.93 [0.86-1.01],0.0744287039657705,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSS,Cathepsin S,Inverse variance weighted,7,0.92 [0.84-1.01],0.076132125386297,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.19 [0.98-1.44],0.0765223365426304,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,35,0.98 [0.96-1],0.0772982019787425,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAYN,Layilin,Inverse variance weighted,3,1.4 [0.96-2.03],0.0773893408453987,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD209,CD209 antigen,Inverse variance weighted,34,0.98 [0.95-1],0.0776231221182193,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,11,1.04 [1-1.09],0.0789367220241502,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.18 [0.98-1.42],0.0797694672421462,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRSS2,Trypsin-2,Inverse variance weighted,17,0.93 [0.85-1.01],0.0801083286080565,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPA1,Carboxypeptidase A1,Inverse variance weighted,26,0.94 [0.87-1.01],0.0802992760460457,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EGLN1,Egl nine homolog 1,Wald ratio,1,0.77 [0.58-1.03],0.0803010821243881,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FETUB,Fetuin-B,Inverse variance weighted,5,1.14 [0.98-1.33],0.0804683933561448,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.08 [0.99-1.17],0.0809547346425269,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.88 [0.75-1.02],0.0810819538874851,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.17 [0.98-1.39],0.0816466968348206,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.05 [0.99-1.11],0.081832882265216,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPE,Carboxypeptidase E,Inverse variance weighted,10,0.91 [0.83-1.01],0.0819015001738647,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.05 [0.99-1.1],0.0822207265341869,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,26,1.05 [0.99-1.12],0.08252876199402,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,0.88 [0.75-1.02],0.0828816797017177,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,12,1.13 [0.98-1.29],0.0848765865289048,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.09 [0.99-1.19],0.0858610187745981,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGMN,Legumain,Inverse variance weighted,22,1.06 [0.99-1.13],0.088735188260881,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.07 [0.99-1.15],0.0888006708977838,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.08 [0.99-1.18],0.0888716238998728,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.08 [0.99-1.18],0.0890810180801751,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,21,1.11 [0.98-1.25],0.0894517705148436,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SEPTIN8,Septin-8,Inverse variance weighted,4,1.12 [0.98-1.27],0.0899518262875847,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.2 [0.97-1.47],0.0903782096064019,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.14 [0.98-1.32],0.0916505290390301,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LPL,Lipoprotein lipase,Inverse variance weighted,8,0.86 [0.73-1.02],0.0919859695803179,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PXN,Paxillin,Inverse variance weighted,7,0.89 [0.78-1.02],0.0921179577522274,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.06 [0.99-1.12],0.0929744888652879,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MSLN,Mesothelin,Inverse variance weighted,11,1.17 [0.97-1.39],0.0952898613508757,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCAN,Brevican core protein,Inverse variance weighted,12,1.12 [0.98-1.27],0.0955250401133066,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.1 [0.98-1.24],0.0956673885741487,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.13 [0.98-1.3],0.0958312378783885,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KYNU,Kynureninase,Inverse variance weighted,3,1.15 [0.98-1.35],0.0967038056463797,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GFRAL,GDNF family receptor alpha-like,Inverse variance weighted,25,0.96 [0.91-1.01],0.0972088319292488,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.92 [0.83-1.02],0.0972505066165774,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.15 [0.97-1.37],0.0983645575338783,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DIPK2B,Divergent protein kinase domain 2B,Inverse variance weighted,9,0.92 [0.83-1.02],0.0994323702004534,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NRP1,Neuropilin-1,Inverse variance weighted,14,1.14 [0.97-1.34],0.100061719851688,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.08 [0.98-1.19],0.100740926428382,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.04 [0.99-1.09],0.100744608504902,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.79 [0.6-1.05],0.101031427632666,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.05 [0.99-1.12],0.101286612844727,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLUL1,Clusterin-like protein 1,Inverse variance weighted,7,0.92 [0.84-1.02],0.102154246007108,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,1.02 [1-1.05],0.102511053433065,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.14 [0.97-1.34],0.10251317934714,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REN,Renin,Inverse variance weighted,8,0.64 [0.38-1.09],0.102549258708811,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HEPH,Hephaestin,Inverse variance weighted,6,0.92 [0.83-1.02],0.103759767932497,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.98 [0.96-1],0.104352393467692,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,11,0.97 [0.93-1.01],0.104975555430455,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,0.98 [0.96-1],0.105099512281419,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.17 [0.97-1.41],0.105277504703725,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,1.05 [0.99-1.11],0.106178373459751,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.1 [0.98-1.23],0.107854145574911,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.88 [0.75-1.03],0.1084531714782,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HJV,Hemojuvelin,Inverse variance weighted,2,1.18 [0.96-1.46],0.109204523500132,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.9 [0.8-1.02],0.110080478046722,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,4,1.19 [0.96-1.48],0.111453833467986,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.11 [0.98-1.25],0.112170029274668,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,59,0.98 [0.96-1],0.112172860797359,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADH1B,All-trans-retinol dehydrogenase,Wald ratio,1,0.87 [0.74-1.03],0.112519462401451,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.89 [0.76-1.03],0.113712232742591,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.94 [0.87-1.02],0.11421892877565,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PI3,Elafin,Inverse variance weighted,18,1.04 [0.99-1.08],0.114448216640149,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MYOM3,Myomesin-3,Inverse variance weighted,24,0.93 [0.85-1.02],0.114792592968458,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.05 [0.99-1.11],0.117326767440209,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CALB1,Calbindin,Inverse variance weighted,9,1.08 [0.98-1.2],0.118532932670522,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OMD,Osteomodulin,Inverse variance weighted,15,0.96 [0.92-1.01],0.119987424727705,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.06 [0.98-1.15],0.120031602994217,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.09 [0.98-1.22],0.121993497889785,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.98 [0.96-1],0.122002484498952,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.14 [0.97-1.34],0.122690629317341,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1R2,Interleukin-1 receptor type 2,Inverse variance weighted,15,0.9 [0.79-1.03],0.124591471556234,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.94 [0.87-1.02],0.125057072585013,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.07 [0.98-1.17],0.125632673151299,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LPO,Lactoperoxidase,Inverse variance weighted,29,0.98 [0.95-1.01],0.126968505281425,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.04 [0.99-1.1],0.128738612989071,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,0.81 [0.63-1.06],0.129513610149922,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.84 [0.68-1.05],0.130403674977414,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNN,Tenascin-N,Inverse variance weighted,41,1.02 [1-1.04],0.131793761785572,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AREG,Amphiregulin,Inverse variance weighted,5,1.12 [0.97-1.29],0.132764460732042,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL22,Interleukin-22,Inverse variance weighted,4,0.76 [0.53-1.09],0.133500824814961,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLB1,"Phospholipase B1, membrane-associated",Inverse variance weighted,30,0.95 [0.88-1.02],0.134554187624567,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,1.09 [0.97-1.22],0.134646704626079,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.07 [0.98-1.16],0.134828652173033,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,0.95 [0.88-1.02],0.135685731390799,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.98 [0.95-1.01],0.138104987670604,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HEXIM1,Protein HEXIM1,Inverse variance weighted,2,1.16 [0.95-1.42],0.138134795372798,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,S100A11,Protein S100-A11,Wald ratio,1,0.84 [0.67-1.06],0.139103434829454,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.05 [0.98-1.12],0.142890004879528,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,1.05 [0.98-1.12],0.143251066084145,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,24,0.97 [0.93-1.01],0.144623804786477,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.97 [0.94-1.01],0.146165684526905,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1.03 [0.99-1.08],0.147209009282519,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.83 [0.65-1.07],0.150253132337206,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.19 [0.94-1.52],0.15102799125652,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.9 [0.78-1.04],0.151620604658539,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EZR,Ezrin,Wald ratio,1,0.83 [0.65-1.07],0.15234643175833,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.16 [0.94-1.43],0.154371327557324,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.07 [0.98-1.17],0.154932026304205,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCAN,Neurocan core protein,Inverse variance weighted,19,1.07 [0.98-1.16],0.156345284706391,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,1.23 [0.92-1.63],0.156731194989736,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.12 [0.96-1.31],0.157790797249618,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,3,0.93 [0.84-1.03],0.158277465492574,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.94 [0.86-1.02],0.158483314331814,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.02 [0.99-1.05],0.161053406535961,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C19orf12,Protein C19orf12,Inverse variance weighted,3,0.91 [0.79-1.04],0.162149732745226,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.99 [0.97-1],0.162878755023803,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.13 [0.95-1.35],0.16392782437143,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.09 [0.97-1.22],0.164578838017875,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.24 [0.91-1.7],0.166330840661898,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.09 [0.96-1.23],0.167570504704239,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS9,Galectin-9,Inverse variance weighted,36,1.02 [0.99-1.05],0.169832777397655,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.98 [0.95-1.01],0.170876095046525,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1.07 [0.97-1.18],0.174318314959657,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.82 [0.62-1.09],0.176815027777325,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.03 [0.99-1.07],0.177630656911758,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL17C,Interleukin-17C,Inverse variance weighted,5,1.09 [0.96-1.22],0.17783613268984,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP10,Stromelysin-2,Wald ratio,1,0.81 [0.6-1.1],0.177979565712446,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.91 [0.8-1.04],0.179483816746002,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,2,1.24 [0.9-1.71],0.180168764464685,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AMBP,Protein AMBP,Inverse variance weighted,5,1.08 [0.96-1.22],0.180782010556469,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.04 [0.98-1.11],0.181169417304015,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOF,Apolipoprotein F,Inverse variance weighted,8,0.89 [0.75-1.06],0.184088623562939,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NRP2,Neuropilin-2,Inverse variance weighted,14,1.08 [0.96-1.21],0.18441068219066,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK15,Kallikrein-15,Inverse variance weighted,7,0.86 [0.69-1.07],0.186198174079361,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PYY,Peptide YY,Inverse variance weighted,16,1.05 [0.98-1.13],0.187299319122157,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.07 [0.97-1.19],0.187400987775037,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.12 [0.95-1.32],0.18856854559942,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DAG1,Dystroglycan,Wald ratio,1,1.22 [0.91-1.63],0.189744190299918,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.96 [0.9-1.02],0.190144587871149,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,0.94 [0.86-1.03],0.190716499520632,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.21 [0.91-1.62],0.192059949401629,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.08 [0.96-1.21],0.194201005945974,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MFGE8,Lactadherin,Inverse variance weighted,15,1.07 [0.97-1.18],0.196685122551037,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.89 [0.74-1.06],0.19739204507659,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,12,1.06 [0.97-1.17],0.199445554681903,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.9 [0.77-1.06],0.19984690672968,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.96 [0.9-1.02],0.200219690102181,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,0.75 [0.48-1.17],0.200970170244089,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ARG1,Arginase-1,Inverse variance weighted,6,0.92 [0.81-1.04],0.203495447627182,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.97 [0.93-1.01],0.204225841330816,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GUCA2A,Guanylin,Inverse variance weighted,7,1.14 [0.93-1.39],0.204344782655972,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.08 [0.96-1.23],0.20579236216755,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.02 [0.99-1.06],0.206347919554316,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,F3,Tissue factor,Inverse variance weighted,13,1.08 [0.96-1.21],0.207163186293547,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LSP1,Lymphocyte-specific protein 1,Wald ratio,1,0.85 [0.66-1.1],0.209404048080562,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.05 [0.97-1.13],0.209938264268891,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.17 [0.91-1.5],0.210782882443257,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.05 [0.97-1.13],0.212604771287295,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.58 [0.77-3.26],0.21291680992992,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.91 [0.79-1.06],0.214008065969169,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPON1,Spondin-1,Inverse variance weighted,4,1.17 [0.91-1.52],0.216302251506101,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.96 [0.9-1.02],0.216833999458269,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,0.82 [0.6-1.12],0.217183153596586,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.96 [0.9-1.02],0.217561527620742,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.19 [0.9-1.56],0.21800770925763,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.04 [0.98-1.1],0.218527902484713,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.87 [0.69-1.09],0.219450419464661,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD83,CD83 antigen,Inverse variance weighted,14,0.95 [0.87-1.03],0.221890720639345,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,0.94 [0.84-1.04],0.222858654000337,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.01 [0.99-1.04],0.224762612364847,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.1 [0.94-1.29],0.225075104179312,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MME,Neprilysin,Inverse variance weighted,46,1.02 [0.99-1.06],0.225958078882424,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KHK,Ketohexokinase,Inverse variance weighted,4,1.09 [0.95-1.24],0.227137931549247,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.86 [0.68-1.1],0.227218993200127,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PALM,Paralemmin-1,Inverse variance weighted,4,0.88 [0.71-1.08],0.228441489397346,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.98 [0.95-1.01],0.229293329980855,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WFDC1,WAP four-disulfide core domain protein 1,Wald ratio,1,1.2 [0.89-1.62],0.230728830784202,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.17 [0.91-1.51],0.230893465743177,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.06 [0.97-1.15],0.231175472914759,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.09 [0.94-1.26],0.232354822708017,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,1.23 [0.87-1.74],0.235241552856923,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,0.85 [0.65-1.11],0.236311594508133,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NFASC,Neurofascin,Inverse variance weighted,6,0.84 [0.64-1.12],0.236389868805507,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.08 [0.95-1.23],0.237128641868219,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.96 [0.89-1.03],0.239022681607582,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SELENOP,Selenoprotein P,Inverse variance weighted,3,1.11 [0.93-1.33],0.242627121284891,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH5,Cadherin-5,Inverse variance weighted,23,0.99 [0.97-1.01],0.246721164687558,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCAM2,Neural cell adhesion molecule 2,Inverse variance weighted,39,0.99 [0.96-1.01],0.24672529210521,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,0.98 [0.94-1.02],0.248586958318303,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.07 [0.96-1.19],0.248595687330891,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,Inverse variance weighted,19,0.98 [0.94-1.02],0.249675256059425,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1.05 [0.96-1.15],0.250258846039238,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.04 [0.98-1.1],0.251241763087838,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COLEC12,Collectin-12,Inverse variance weighted,3,0.79 [0.53-1.18],0.252729997606331,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",Inverse variance weighted,4,1.09 [0.94-1.25],0.252748175633938,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,INHBC,Inhibin beta C chain,Inverse variance weighted,12,0.95 [0.87-1.04],0.252962091390776,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,P4HB,Protein disulfide-isomerase,Inverse variance weighted,4,0.86 [0.66-1.12],0.257573017051998,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MPO,Myeloperoxidase,Inverse variance weighted,17,1.03 [0.98-1.09],0.257986183566837,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.95 [0.86-1.04],0.261432059740631,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.07 [0.95-1.19],0.262504288721138,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,2,0.91 [0.76-1.08],0.263419228986849,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PVR,Poliovirus receptor,Inverse variance weighted,3,1.11 [0.92-1.34],0.265793585720019,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GUSB,Beta-glucuronidase,Inverse variance weighted,31,1.03 [0.98-1.09],0.265951711845842,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MUC13,Mucin-13,Inverse variance weighted,3,0.86 [0.67-1.12],0.267193927949726,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL28,C-C motif chemokine 28,Inverse variance weighted,30,1.03 [0.98-1.08],0.267631873289629,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.06 [0.96-1.17],0.267923153256171,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.14 [0.9-1.45],0.268013945575473,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.04 [0.97-1.12],0.26830985027008,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,0.97 [0.93-1.02],0.268967177572517,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.04 [0.97-1.11],0.269377404053421,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MAP2,Microtubule-associated protein 2,Inverse variance weighted,8,1.19 [0.88-1.61],0.269382984841509,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.95 [0.86-1.04],0.271034991130929,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PENK,Proenkephalin-A,Inverse variance weighted,15,1.05 [0.96-1.14],0.271063168183206,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.11 [0.92-1.32],0.271535504310185,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.96 [0.9-1.03],0.271987380397469,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK11,Kallikrein-11,Inverse variance weighted,13,1.04 [0.97-1.11],0.273113421423721,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,0.89 [0.71-1.1],0.274503701410072,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL16,Pro-interleukin-16,Inverse variance weighted,6,1.12 [0.91-1.37],0.275340702317097,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.14 [0.9-1.44],0.275794783400783,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,0.94 [0.85-1.05],0.277789756006661,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,2,1.19 [0.87-1.63],0.278728858996106,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL10,Interleukin-10,Inverse variance weighted,4,0.97 [0.92-1.02],0.279359531504115,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,Inverse variance weighted,2,0.82 [0.58-1.17],0.279516203898909,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EGFLAM,Pikachurin,Wald ratio,1,1.24 [0.84-1.84],0.280019952079091,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NOMO1,Nodal modulator 1,Inverse variance weighted,24,0.99 [0.96-1.01],0.28079847655366,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,0.96 [0.89-1.04],0.282102638419805,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.94 [0.83-1.05],0.283112501607457,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCG3,Secretogranin-3,Inverse variance weighted,16,1.05 [0.96-1.13],0.283610814337627,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPB2,Carboxypeptidase B2,Inverse variance weighted,4,0.9 [0.75-1.09],0.28610520032133,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,4,0.93 [0.82-1.06],0.286571467240137,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSD,Cathepsin D,Inverse variance weighted,7,1.1 [0.92-1.32],0.28665864916666,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD276,CD276 antigen,Inverse variance weighted,24,0.97 [0.92-1.02],0.28726420687891,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Inverse variance weighted,19,1.03 [0.98-1.09],0.287567405036341,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.01 [0.99-1.03],0.289103527357427,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,0.97 [0.93-1.02],0.290029251739301,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.93 [0.81-1.06],0.290716438827318,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,0.97 [0.91-1.03],0.290740859884048,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTSL5,ADAMTS-like protein 5,Inverse variance weighted,3,0.95 [0.86-1.04],0.290875244687478,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.87 [0.66-1.14],0.29611503547974,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.86 [0.65-1.14],0.296899217265153,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.89 [0.72-1.11],0.298050071952818,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.99 [0.97-1.01],0.302129013482068,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.1 [0.92-1.32],0.304397246895513,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PBLD,Phenazine biosynthesis-like domain-containing protein,Inverse variance weighted,22,0.99 [0.96-1.01],0.305077315726088,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,3,1.11 [0.91-1.34],0.305429578434223,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.16 [0.87-1.54],0.307178251050014,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDKN1A,Cyclin-dependent kinase inhibitor 1,Inverse variance weighted,2,0.65 [0.29-1.49],0.308684507679766,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL5,C-C motif chemokine 5,Inverse variance weighted,8,1.07 [0.94-1.21],0.310930190260304,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,1.03 [0.98-1.08],0.311798008707816,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.23 [0.82-1.85],0.313900593412642,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.11 [0.91-1.35],0.313904187294889,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.9 [0.73-1.11],0.315120193161844,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.95 [0.87-1.05],0.317481675668358,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.05 [0.95-1.16],0.317707001831869,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS3,Galectin-3,Inverse variance weighted,15,0.96 [0.9-1.04],0.319370251980961,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.98 [0.93-1.02],0.319940360956652,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.05 [0.95-1.17],0.323907022760389,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.92 [0.77-1.09],0.324857931230921,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,1.06 [0.94-1.19],0.326120539284073,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH1,Cadherin-1,Inverse variance weighted,16,0.97 [0.9-1.04],0.330060239599117,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.04 [0.96-1.12],0.331336544972073,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,1.14 [0.88-1.48],0.331365243363468,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,S100P,Protein S100-P,Inverse variance weighted,4,0.92 [0.77-1.09],0.333041155530291,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.97 [0.92-1.03],0.333805459744719,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCT,Secretin,Inverse variance weighted,5,0.9 [0.72-1.12],0.334506072601159,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRTN3,Myeloblastin,Inverse variance weighted,20,0.97 [0.92-1.03],0.335273853981158,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.03 [0.97-1.11],0.335301953045281,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.16 [0.86-1.56],0.337951053830249,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,1.05 [0.95-1.17],0.338631165446003,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRYBB2,Beta-crystallin B2,Inverse variance weighted,30,1.02 [0.98-1.07],0.344879839098466,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KITLG,Kit ligand,Inverse variance weighted,30,1.02 [0.98-1.07],0.345920429102838,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MB,Myoglobin,Inverse variance weighted,9,0.93 [0.8-1.08],0.346118428369488,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,1.11 [0.9-1.36],0.347166658258404,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,1.15 [0.86-1.55],0.347309664612078,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.54 [0.62-3.79],0.348821892515477,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.26 [0.78-2.03],0.349075114868417,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,25,0.96 [0.89-1.04],0.349267480855624,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.96 [0.89-1.04],0.349669836691656,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,1.15 [0.86-1.52],0.349952502493218,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.93 [0.8-1.08],0.351079682986557,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,0.9 [0.71-1.13],0.353592146313569,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.94 [0.82-1.08],0.354703958831924,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LEP,Leptin,Inverse variance weighted,4,1.57 [0.6-4.11],0.355700550267181,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.12 [0.88-1.43],0.356455426776713,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HMOX2,Heme oxygenase 2,Inverse variance weighted,3,0.94 [0.84-1.07],0.35688914638103,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPB1,Carboxypeptidase B,Inverse variance weighted,18,0.95 [0.84-1.06],0.357890445070766,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.02 [0.98-1.07],0.360382424633915,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,20,1.04 [0.96-1.12],0.361057064073244,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.97 [0.9-1.04],0.362423372517248,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.96 [0.87-1.05],0.362968425842093,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.13 [0.87-1.48],0.365080956795055,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,UMOD,Uromodulin,Inverse variance weighted,34,1.04 [0.96-1.13],0.365389040057566,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.04 [0.96-1.13],0.365782945165374,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,0.95 [0.84-1.07],0.366079996672195,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KCTD5,BTB/POZ domain-containing protein KCTD5,Inverse variance weighted,5,1.09 [0.9-1.31],0.366778958123452,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.95 [0.86-1.06],0.368479698697461,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.96 [0.87-1.05],0.369180188420985,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.02 [0.98-1.07],0.370318760122386,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,1.05 [0.95-1.16],0.371705881829144,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.01 [0.98-1.05],0.372180365309332,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,1.16 [0.84-1.6],0.372204520262013,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.94 [0.82-1.08],0.374327740803598,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,1.06 [0.93-1.2],0.380439145333823,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.03 [0.96-1.11],0.381634291769843,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.09 [0.89-1.34],0.385886833132799,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,0.92 [0.76-1.11],0.387752235235882,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HTRA2,"Serine protease HTRA2, mitochondrial",Wald ratio,1,1.12 [0.87-1.45],0.391052328140882,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGA,Fibrinogen alpha chain,Inverse variance weighted,6,0.95 [0.85-1.07],0.392337614162748,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRELP,Prolargin,Inverse variance weighted,5,0.89 [0.67-1.17],0.393320441681411,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.92 [0.75-1.12],0.393459780099845,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,1.05 [0.94-1.17],0.394289774312043,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,0.87 [0.63-1.2],0.395430537132285,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.97 [0.91-1.04],0.395632192888828,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,4,0.96 [0.88-1.05],0.398821710437109,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,33,0.99 [0.97-1.01],0.399796726778077,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.03 [0.96-1.1],0.401051929004217,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.92 [0.76-1.12],0.401445923503001,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1.11 [0.87-1.42],0.402835506881748,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,1.04 [0.95-1.14],0.40332955218086,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CST7,Cystatin-F,Inverse variance weighted,46,0.98 [0.94-1.02],0.404375690579458,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FUOM,Fucose mutarotase,Inverse variance weighted,6,1.05 [0.93-1.18],0.405771340291674,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,15,0.94 [0.83-1.08],0.405967980082806,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.04 [0.94-1.15],0.406263100337901,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CREG1,Protein CREG1,Inverse variance weighted,20,1.03 [0.96-1.09],0.406361793786071,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACTN2,Alpha-actinin-2,Inverse variance weighted,4,1.06 [0.93-1.21],0.408117728827385,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IDS,Iduronate 2-sulfatase,Inverse variance weighted,3,1.06 [0.92-1.24],0.410841193139077,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TCOF1,Treacle protein,Wald ratio,1,1.13 [0.85-1.5],0.410842797296141,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGFBP3,Fibroblast growth factor-binding protein 3,Inverse variance weighted,43,0.99 [0.97-1.01],0.413065112693467,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,10,0.93 [0.77-1.11],0.414030404020568,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.05 [0.93-1.18],0.415193623968432,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,0.89 [0.68-1.17],0.41547513077335,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,17,1.03 [0.96-1.1],0.41604992653655,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.92 [0.75-1.13],0.416743103507203,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,20,1.03 [0.96-1.1],0.417243735464161,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHL1,Neural cell adhesion molecule L1-like protein,Inverse variance weighted,11,0.94 [0.81-1.09],0.417435857878915,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,1.1 [0.87-1.4],0.41795214526919,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.94 [0.82-1.08],0.418305628833348,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.94 [0.82-1.09],0.418769191991638,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,3,0.85 [0.58-1.26],0.418914501727501,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.97 [0.89-1.05],0.419703707010892,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.95 [0.85-1.07],0.420682554617688,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGRN,Agrin,Inverse variance weighted,14,1.06 [0.92-1.21],0.421211809925873,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,1.19 [0.78-1.81],0.421933507069272,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1.01 [0.98-1.05],0.422521601343422,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.93 [0.78-1.11],0.422607598971413,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCLY,Selenocysteine lyase,Inverse variance weighted,4,0.94 [0.82-1.09],0.423095049231077,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.99 [0.96-1.02],0.425239066054463,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.97 [0.9-1.05],0.42727005224432,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.01 [0.98-1.04],0.431001057203741,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,21,1.02 [0.97-1.07],0.432717145065546,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.93 [0.77-1.12],0.434089404760959,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,20,0.96 [0.86-1.07],0.434110089740069,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPP1,Osteopontin,Inverse variance weighted,13,1.04 [0.94-1.14],0.434177148426116,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.99 [0.96-1.02],0.434827854694187,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.1 [0.86-1.41],0.441392519654845,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL1A1,Collagen alpha-1(I) chain,Inverse variance weighted,16,1.05 [0.93-1.19],0.442346787521046,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.94 [0.81-1.1],0.444867744273247,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.05 [0.93-1.19],0.447095866528654,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BPIFA2,BPI fold-containing family A member 2,Inverse variance weighted,40,1.01 [0.98-1.04],0.44716544596422,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,1.05 [0.93-1.19],0.447709178020158,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.97 [0.9-1.05],0.44833401133281,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,1.02 [0.97-1.08],0.448843215841433,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FLT4,Vascular endothelial growth factor receptor 3,Inverse variance weighted,60,0.99 [0.97-1.02],0.449213589316979,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP1,Interstitial collagenase,Inverse variance weighted,14,0.96 [0.85-1.07],0.45164032861666,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DRAXIN,Draxin,Inverse variance weighted,25,1.03 [0.96-1.11],0.452024517440039,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,0.89 [0.65-1.21],0.454330300489925,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CFC1,Cryptic protein,Inverse variance weighted,11,0.96 [0.85-1.07],0.454784345982688,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL15,Interleukin-15,Inverse variance weighted,35,1.02 [0.97-1.06],0.455592270427516,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.87 [0.59-1.27],0.455822378916199,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BSG,Basigin,Inverse variance weighted,6,1.08 [0.88-1.33],0.457070464894142,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CES1,Liver carboxylesterase 1,Inverse variance weighted,19,1.03 [0.95-1.13],0.457148068451207,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.84 [0.52-1.34],0.458042867129296,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CAPG,Macrophage-capping protein,Wald ratio,1,0.92 [0.73-1.15],0.458056270986629,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC3B,Tetranectin,Inverse variance weighted,2,1.09 [0.87-1.35],0.45867963589782,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.9 [0.68-1.19],0.461554884172191,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,0.97 [0.91-1.04],0.462976825647119,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL19,Interleukin-19,Inverse variance weighted,10,1.02 [0.96-1.09],0.463727736766037,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AFM,Afamin,Inverse variance weighted,8,1.07 [0.9-1.27],0.463965852202835,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MET,Hepatocyte growth factor receptor,Inverse variance weighted,21,0.96 [0.86-1.07],0.467416923752671,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.06 [0.91-1.22],0.46916288846627,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.97 [0.89-1.05],0.472386833601285,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.99 [0.95-1.02],0.475013770656449,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PKD1,Polycystin-1,Inverse variance weighted,12,1.05 [0.93-1.18],0.476569021581522,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.96 [0.87-1.07],0.477025029222581,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.92 [0.72-1.16],0.478296939015912,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.01 [0.98-1.05],0.478298809218681,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.97 [0.91-1.05],0.481472690830488,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.07 [0.88-1.3],0.4832725494007,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PSAP,Prosaposin,Inverse variance weighted,13,1.02 [0.97-1.07],0.484350370657075,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,0.98 [0.92-1.04],0.4854343633638,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.97 [0.91-1.05],0.485670232578918,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SELP,P-selectin,Inverse variance weighted,4,1.06 [0.9-1.24],0.488970264544404,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ALCAM,CD166 antigen,Inverse variance weighted,4,0.97 [0.9-1.05],0.489175236649912,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.02 [0.97-1.07],0.489660067286688,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NIT2,Omega-amidase NIT2,Inverse variance weighted,2,0.9 [0.68-1.21],0.489928907764513,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,37,1.02 [0.97-1.07],0.490516942011934,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NGRN,Neugrin,Inverse variance weighted,4,0.95 [0.82-1.1],0.493556792787994,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.02 [0.96-1.09],0.495033820680819,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.99 [0.96-1.02],0.496719543616544,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,POF1B,Protein POF1B,Inverse variance weighted,4,0.95 [0.83-1.09],0.496756861987341,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.92 [0.74-1.16],0.499063260348095,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,1.11 [0.82-1.49],0.49980691737935,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,0.98 [0.91-1.05],0.50065323315606,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.95 [0.82-1.1],0.501970219695487,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,5,1.04 [0.92-1.18],0.507316032880478,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,59,1.01 [0.99-1.03],0.510038138672545,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.98 [0.92-1.04],0.51095607846411,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SDC1,Syndecan-1,Inverse variance weighted,12,1.03 [0.94-1.12],0.513597403627066,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SMAD5,Mothers against decapentaplegic homolog 5,Inverse variance weighted,8,0.98 [0.93-1.04],0.514386397984487,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,A1BG,Alpha-1B-glycoprotein,Inverse variance weighted,4,1.06 [0.9-1.24],0.515638066567062,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.05 [0.91-1.22],0.516150343186135,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.04 [0.93-1.16],0.517477772768848,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.02 [0.95-1.1],0.51843103437697,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.07 [0.87-1.31],0.523564488626745,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,0.98 [0.92-1.05],0.523758012846206,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.96 [0.83-1.1],0.525492271814215,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.06 [0.88-1.29],0.526689698490769,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.06 [0.88-1.29],0.526767931619959,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL6,Interleukin-6,Inverse variance weighted,6,1.03 [0.94-1.12],0.528775904533474,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CSTB,Cystatin-B,Inverse variance weighted,23,1.01 [0.98-1.03],0.530503683522219,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,40,0.99 [0.95-1.03],0.530802058418449,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.89 [0.62-1.28],0.533842758801798,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.95 [0.82-1.11],0.533961902743153,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GCG,Pro-glucagon,Inverse variance weighted,2,0.94 [0.78-1.14],0.537578620145792,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.88 [0.58-1.33],0.538281051022911,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.01 [0.97-1.05],0.539248475512024,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLF4,Krueppel-like factor 4,Wald ratio,1,1.14 [0.75-1.73],0.539973199260264,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.88 [0.58-1.33],0.541535444518539,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WNT9A,Protein Wnt-9a,Wald ratio,1,1.11 [0.79-1.56],0.543500245306345,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.06 [0.88-1.27],0.544845696692251,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,0.96 [0.83-1.1],0.545623682260598,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CNTN1,Contactin-1,Inverse variance weighted,25,1.02 [0.95-1.09],0.546013640078492,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD248,Endosialin,Inverse variance weighted,17,1.03 [0.93-1.15],0.547621490816576,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LMNB2,Lamin-B2,Inverse variance weighted,8,1.05 [0.9-1.21],0.550723667930156,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CST6,Cystatin-M,Inverse variance weighted,26,1.02 [0.96-1.09],0.556287675607117,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.04 [0.9-1.21],0.55877678494897,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDHR2,Cadherin-related family member 2,Inverse variance weighted,13,1.05 [0.89-1.25],0.560544055219125,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1 [0.98-1.01],0.562111508565017,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.96 [0.85-1.09],0.562193378824863,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK4,Kallikrein-4,Inverse variance weighted,5,0.89 [0.59-1.33],0.564964010294648,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.98 [0.92-1.05],0.565115012265671,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.92 [0.69-1.23],0.565164671736788,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,1.01 [0.97-1.07],0.56695264008154,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.02 [0.95-1.09],0.568091536469134,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLG,Plasminogen,Inverse variance weighted,6,1.03 [0.92-1.16],0.568755843571013,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.04 [0.91-1.18],0.568985484606334,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FBLN2,Fibulin-2,Inverse variance weighted,6,1.06 [0.87-1.3],0.57057647314953,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PALM2,Paralemmin-2,Inverse variance weighted,9,1.02 [0.96-1.08],0.572562936929019,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.03 [0.92-1.17],0.57392212151605,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,0.96 [0.82-1.11],0.574484186677091,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.08 [0.83-1.39],0.575126988698791,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.88 [0.56-1.38],0.577108881317691,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.95 [0.78-1.15],0.578532176642474,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FURIN,Furin,Inverse variance weighted,3,0.96 [0.83-1.11],0.579513038041807,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.96 [0.84-1.1],0.580334374823878,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.02 [0.96-1.08],0.581451940038375,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Wald ratio,1,0.82 [0.41-1.64],0.582025052865275,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.01 [0.98-1.03],0.583456560823491,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,0.82 [0.41-1.66],0.584777921382775,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,0.95 [0.8-1.14],0.587382230365185,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ELN,Elastin,Inverse variance weighted,10,1.02 [0.94-1.12],0.587579215774663,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSL,Cathepsin L1,Inverse variance weighted,29,1.01 [0.96-1.07],0.588442291836963,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1.02 [0.94-1.11],0.591280100270584,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.99 [0.94-1.04],0.592070271180057,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,5,1.03 [0.91-1.17],0.592375976014962,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ZNRD2,Protein ZNRD2,Inverse variance weighted,10,1.02 [0.94-1.11],0.59305742537827,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LMNB1,Lamin-B1,Inverse variance weighted,3,0.96 [0.84-1.11],0.593319371031306,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,1.01 [0.97-1.05],0.5939100260275,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.02 [0.95-1.1],0.596126140006899,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.01 [0.98-1.04],0.598165365663452,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RGMB,RGM domain family member B,Inverse variance weighted,5,1.04 [0.9-1.19],0.60028481246777,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.03 [0.93-1.13],0.601788737165817,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.9 [0.62-1.32],0.602125901572587,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Wald ratio,1,0.89 [0.58-1.38],0.607198305382563,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SMTN,Smoothelin,Wald ratio,1,0.95 [0.79-1.15],0.607322311951369,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,1.08 [0.81-1.42],0.607449372367688,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NECTIN2,Nectin-2,Inverse variance weighted,3,1.19 [0.62-2.27],0.608031042834197,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,9,0.98 [0.9-1.07],0.608862810408986,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DCXR,L-xylulose reductase,Inverse variance weighted,9,1.03 [0.91-1.16],0.610898885862737,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD99,CD99 antigen,Inverse variance weighted,4,0.96 [0.82-1.12],0.611070154623446,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAMP2,Lysosome-associated membrane glycoprotein 2,Inverse variance weighted,6,0.96 [0.82-1.12],0.611483308842899,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCAMP3,Secretory carrier-associated membrane protein 3,Wald ratio,1,1.06 [0.86-1.3],0.61314834993386,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGT,Angiotensinogen,Wald ratio,1,0.95 [0.8-1.14],0.615364022312831,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.94 [0.73-1.2],0.616206256171024,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HHEX,Hematopoietically-expressed homeobox protein HHEX,Wald ratio,1,0.93 [0.69-1.25],0.61867220744694,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.01 [0.96-1.07],0.619352085365031,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SORT1,Sortilin,Inverse variance weighted,11,1.03 [0.91-1.17],0.619778068232895,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.03 [0.91-1.17],0.622982137086595,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.08 [0.79-1.47],0.626318371697089,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.02 [0.95-1.09],0.628248214057682,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.06 [0.84-1.34],0.629897127252905,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,0.97 [0.86-1.1],0.631538825080308,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.98-1.03],0.633950390369963,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL11,Eotaxin,Inverse variance weighted,11,0.98 [0.92-1.05],0.634567354375473,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.03 [0.92-1.14],0.635264335067903,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.97 [0.86-1.1],0.635463934095764,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,1.03 [0.92-1.15],0.635887852511518,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTGES2,Prostaglandin E synthase 2,Inverse variance weighted,2,1.06 [0.84-1.34],0.63641620442916,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.99 [0.95-1.03],0.637164897386131,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.04 [0.89-1.2],0.637442250566476,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,1.07 [0.82-1.39],0.638234614629687,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CFI,Complement factor I,Wald ratio,1,0.92 [0.64-1.32],0.639768398564801,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.94 [0.71-1.23],0.64207246851503,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,5,1.04 [0.87-1.25],0.642278239123873,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CX3CL1,Fractalkine,Inverse variance weighted,12,0.96 [0.81-1.14],0.642897577321028,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.99 [0.95-1.03],0.643475678789046,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,1.05 [0.85-1.3],0.64393768559666,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.01 [0.95-1.08],0.644124426278095,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.03 [0.9-1.18],0.644454190969487,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.99-1.02],0.64456372480322,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.05 [0.86-1.28],0.646633017610811,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.02 [0.94-1.11],0.648283398515731,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,1.04 [0.86-1.26],0.650671885135439,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,11,0.96 [0.81-1.14],0.652908297046755,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NECTIN4,Nectin-4,Inverse variance weighted,4,0.96 [0.81-1.14],0.653493713990121,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.03 [0.92-1.15],0.654128616977491,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,F2R,Proteinase-activated receptor 1,Inverse variance weighted,6,0.98 [0.89-1.07],0.655641876080767,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.03 [0.91-1.16],0.656526496808988,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.98 [0.91-1.06],0.656793276825012,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.05 [0.85-1.29],0.656886193379653,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.06 [0.83-1.34],0.657151096122349,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PPP3R1,Calcineurin subunit B type 1,Inverse variance weighted,3,0.98 [0.88-1.08],0.658415640776311,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.99 [0.96-1.02],0.659857164752868,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,0.99 [0.95-1.03],0.661125035939693,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,3,0.95 [0.75-1.2],0.661751246594859,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.12 [0.66-1.91],0.663475110098419,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,1.02 [0.94-1.11],0.663899226143313,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.98 [0.89-1.08],0.664836162189697,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GBP1,Guanylate-binding protein 1,Inverse variance weighted,4,0.98 [0.9-1.07],0.665101245992119,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.99 [0.96-1.03],0.665283360881974,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.96 [0.8-1.15],0.666704996919755,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRH,Corticoliberin,Inverse variance weighted,55,1.01 [0.97-1.04],0.666754537294503,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,0.98 [0.91-1.06],0.668973852154833,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.07 [0.79-1.43],0.670063966928391,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.98 [0.89-1.08],0.670900370565605,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.99 [0.95-1.04],0.673183630594782,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD48,CD48 antigen,Inverse variance weighted,14,1.02 [0.92-1.15],0.675717486021875,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,1.01 [0.97-1.05],0.675797894655369,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OGN,Mimecan,Inverse variance weighted,37,0.99 [0.96-1.03],0.677764731700801,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.99 [0.93-1.05],0.682362141309974,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.9 [0.53-1.53],0.683466907092878,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1.02 [0.93-1.12],0.687579179223676,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS4,Galectin-4,Inverse variance weighted,15,0.99 [0.95-1.04],0.687793717585431,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,6,0.98 [0.89-1.08],0.687961104073931,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TSPAN8,Tetraspanin-8,Inverse variance weighted,19,1.01 [0.95-1.09],0.688228711404082,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.02 [0.92-1.13],0.690907815827111,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,0.99 [0.92-1.06],0.691546059178126,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TSHB,Thyrotropin subunit beta,Inverse variance weighted,31,1.01 [0.97-1.05],0.695834145347744,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,F7,Coagulation factor VII,Inverse variance weighted,10,0.97 [0.82-1.15],0.695995528928278,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHGA,Chromogranin-A,Inverse variance weighted,5,0.98 [0.87-1.1],0.696059717484409,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPINB8,Serpin B8,Inverse variance weighted,29,1 [0.98-1.01],0.696080016564058,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.02 [0.92-1.13],0.698268069840345,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,0.98 [0.89-1.08],0.698361623075399,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,0.98 [0.91-1.07],0.699112786629923,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.98 [0.88-1.09],0.6991266247578,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TALDO1,Transaldolase,Wald ratio,1,0.89 [0.49-1.62],0.70062095354948,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MVK,Mevalonate kinase,Wald ratio,1,0.89 [0.49-1.62],0.70062095354948,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD302,CD302 antigen,Inverse variance weighted,11,1.02 [0.94-1.1],0.70166188418149,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.97 [0.83-1.14],0.701975770738875,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1.05 [0.82-1.35],0.702044669955341,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FIS1,Mitochondrial fission 1 protein,Inverse variance weighted,3,1.03 [0.89-1.19],0.703561448869133,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.02 [0.93-1.12],0.705144616044608,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP6,Gastrotropin,Inverse variance weighted,4,0.97 [0.85-1.12],0.707606191224869,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS8,Galectin-8,Inverse variance weighted,8,0.98 [0.89-1.08],0.708611169037403,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,14,1.01 [0.95-1.09],0.708849630412846,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPC5,Glypican-5,Inverse variance weighted,42,1 [0.98-1.03],0.709708757226955,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.96 [0.75-1.22],0.710274544135453,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.01 [0.94-1.09],0.712006149756213,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.98 [0.9-1.08],0.714012046365666,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,0.99 [0.93-1.05],0.714467297400081,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.02 [0.9-1.17],0.71680603582452,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.05 [0.81-1.36],0.719685154820497,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PI16,Peptidase inhibitor 16,Inverse variance weighted,22,1.01 [0.97-1.05],0.719917993210731,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.02 [0.91-1.15],0.720190733859595,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLIN1,Perilipin-1,Wald ratio,1,1.05 [0.81-1.35],0.720782647570632,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RETN,Resistin,Inverse variance weighted,19,0.98 [0.89-1.08],0.720836895933436,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,15,0.97 [0.84-1.13],0.721397619620505,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PROK1,Prokineticin-1,Inverse variance weighted,4,1.11 [0.63-1.96],0.721519045377999,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OSM,Oncostatin-M,Inverse variance weighted,6,0.98 [0.89-1.08],0.721777038314098,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGRP,Agouti-related protein,Inverse variance weighted,16,1.01 [0.95-1.08],0.723280727531446,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.05 [0.79-1.4],0.723351728423167,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,21,1.01 [0.94-1.09],0.723715574718686,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.02 [0.9-1.17],0.724736824092748,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,0.96 [0.74-1.23],0.726266752461946,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PKD2,Polycystin-2,Inverse variance weighted,3,1.07 [0.74-1.54],0.72664193217832,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTN,Pleiotrophin,Inverse variance weighted,3,0.97 [0.81-1.16],0.729181075483932,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTH,Parathyroid hormone,Inverse variance weighted,11,1.02 [0.89-1.17],0.729307521593376,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.97 [0.84-1.13],0.729381418534177,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,L1CAM,Neural cell adhesion molecule L1,Inverse variance weighted,21,0.98 [0.89-1.08],0.729420278416909,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.97 [0.84-1.13],0.73412601818496,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1 [0.97-1.02],0.736720275449527,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.96 [0.74-1.23],0.736741953827775,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.99 [0.96-1.03],0.738248291152587,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,4,0.98 [0.87-1.1],0.73907871323155,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.04 [0.82-1.32],0.739449953901565,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,0.95 [0.72-1.26],0.74222468408458,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,Inverse variance weighted,12,0.97 [0.82-1.15],0.742451772479462,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.08 [0.68-1.71],0.743524639508932,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TCTN3,Tectonic-3,Inverse variance weighted,44,1 [0.98-1.03],0.744048926369517,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.05 [0.79-1.4],0.745558582385706,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHAD,Chondroadherin,Inverse variance weighted,15,0.99 [0.95-1.04],0.74687973746956,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MYBPC2,"Myosin-binding protein C, fast-type",Inverse variance weighted,4,1.02 [0.89-1.17],0.746975923542219,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH2,Cadherin-2,Inverse variance weighted,21,1.01 [0.93-1.11],0.748355504016601,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.98 [0.85-1.12],0.748891101283834,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.02 [0.9-1.16],0.749475276981569,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.01 [0.94-1.08],0.751066122699882,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,0.99 [0.95-1.04],0.751472941184019,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,1.02 [0.92-1.13],0.752178344112332,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.97 [0.82-1.16],0.753053008692626,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,XG,Glycoprotein Xg,Inverse variance weighted,2,1.03 [0.84-1.27],0.756278324536585,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RTBDN,Retbindin,Inverse variance weighted,2,0.97 [0.83-1.15],0.758243038063762,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.1 [0.6-1.99],0.759618829397723,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFNLR1,Interferon lambda receptor 1,Wald ratio,1,1.03 [0.83-1.29],0.759740583463783,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.01 [0.93-1.1],0.762839866609485,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,1.05 [0.77-1.44],0.762887651681972,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,THBD,Thrombomodulin,Inverse variance weighted,11,0.99 [0.9-1.08],0.765438768612149,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.04 [0.79-1.37],0.766336446538318,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.98 [0.89-1.09],0.767333470931213,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.99 [0.9-1.09],0.770884633036846,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.97 [0.78-1.2],0.773652609010584,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AMN,Protein amnionless,Inverse variance weighted,3,0.97 [0.76-1.23],0.774040772860374,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHGB,Secretogranin-1,Inverse variance weighted,7,0.96 [0.73-1.26],0.774861507721135,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH6,Cadherin-6,Inverse variance weighted,5,1.02 [0.9-1.15],0.774873820697789,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.03 [0.82-1.31],0.776602935153477,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLITRK1,SLIT and NTRK-like protein 1,Inverse variance weighted,6,1.02 [0.9-1.15],0.778823758518918,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPON2,Spondin-2,Inverse variance weighted,3,1.05 [0.73-1.53],0.779211639064205,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.98 [0.82-1.16],0.780750542372086,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CXCL6,C-X-C motif chemokine 6,Inverse variance weighted,9,1.02 [0.9-1.14],0.781185596820248,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.02 [0.86-1.21],0.782602708652514,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,1.01 [0.91-1.13],0.784140669121581,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NADK,NAD kinase,Inverse variance weighted,7,0.98 [0.83-1.15],0.784441161570915,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,1.05 [0.76-1.44],0.7857785363637,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.01 [0.92-1.11],0.786071554532899,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.01 [0.93-1.1],0.786239789481807,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,0.98 [0.87-1.11],0.787603931255047,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.97 [0.8-1.19],0.789122545120853,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.99 [0.91-1.08],0.789161098586023,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APLP1,Amyloid-like protein 1,Inverse variance weighted,9,0.99 [0.93-1.06],0.789541254114498,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TTR,Transthyretin,Inverse variance weighted,11,1.02 [0.9-1.15],0.790637699954314,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.03 [0.85-1.24],0.790900713182343,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1 [0.97-1.02],0.791618987249679,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,2,1.05 [0.74-1.47],0.791804947794412,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,0.99 [0.9-1.08],0.792065679403858,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,4,0.98 [0.87-1.11],0.793146816056842,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.01 [0.94-1.09],0.794534116474981,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.98 [0.83-1.15],0.794966707989847,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,1.01 [0.96-1.05],0.79558325572423,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.98 [0.85-1.13],0.797404514998518,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,UPB1,Beta-ureidopropionase,Wald ratio,1,1.1 [0.54-2.22],0.79751610443141,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.02 [0.9-1.15],0.79881789359268,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,XCL1,Lymphotactin,Inverse variance weighted,15,0.99 [0.92-1.06],0.798932218682053,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.03 [0.8-1.33],0.802238064739539,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.06 [0.68-1.63],0.802712254944166,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GSN,Gelsolin,Inverse variance weighted,7,1.01 [0.91-1.13],0.803024987513284,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL18,Interleukin-18,Inverse variance weighted,26,1.01 [0.96-1.05],0.803727554738602,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,0.99 [0.9-1.09],0.806219955729753,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD27,CD27 antigen,Inverse variance weighted,9,0.98 [0.82-1.17],0.806514307367065,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.01 [0.92-1.12],0.808892073087716,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SHMT1,"Serine hydroxymethyltransferase, cytosolic",Inverse variance weighted,4,1.01 [0.92-1.12],0.809143385285463,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.03 [0.8-1.33],0.809162220990034,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.03 [0.81-1.31],0.814983136140533,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ATOX1,Copper transport protein ATOX1,Wald ratio,1,0.99 [0.88-1.1],0.815042742118982,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.01 [0.91-1.12],0.81672467150764,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.03 [0.8-1.33],0.817101365841531,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PRSS8,Prostasin,Inverse variance weighted,14,0.99 [0.93-1.06],0.822432115714225,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,1.02 [0.85-1.23],0.822974979179401,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.99 [0.94-1.05],0.823128128746147,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.99 [0.89-1.1],0.823161024660395,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.97 [0.77-1.23],0.824496064796236,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,11,1.01 [0.92-1.12],0.825148087319999,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.99 [0.89-1.1],0.832714296654092,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,1.04 [0.73-1.47],0.833394347213083,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,1.01 [0.95-1.07],0.835182017942111,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,1 [0.98-1.03],0.835674676029257,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MILR1,Allergin-1,Inverse variance weighted,43,1 [0.98-1.01],0.837487485448508,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1 [0.96-1.05],0.837845904173139,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LCN15,Lipocalin-15,Inverse variance weighted,22,1 [0.98-1.02],0.838439842829221,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCN4,CCN family member 4,Inverse variance weighted,29,1 [0.96-1.04],0.839535822713164,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CFD,Complement factor D,Wald ratio,1,0.97 [0.75-1.26],0.840334225513635,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FAM3B,Protein FAM3B,Inverse variance weighted,26,1 [0.98-1.03],0.840999423570321,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GKN1,Gastrokine-1,Inverse variance weighted,3,0.99 [0.87-1.12],0.843435792262864,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.97 [0.7-1.34],0.843800669406108,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,16,1.01 [0.95-1.07],0.844057919253911,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PSIP1,PC4 and SFRS1-interacting protein,Wald ratio,1,0.97 [0.72-1.31],0.845564812918382,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1 [0.97-1.04],0.845846465982022,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,0.99 [0.86-1.13],0.847319940005123,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.01 [0.9-1.13],0.853032039707411,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,THBS2,Thrombospondin-2,Inverse variance weighted,15,1 [0.96-1.05],0.854937733804169,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MATN2,Matrilin-2,Inverse variance weighted,28,1 [0.97-1.03],0.860642242450686,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CR2,Complement receptor type 2,Inverse variance weighted,36,0.99 [0.93-1.06],0.86305077364681,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1 [0.95-1.05],0.863867610727203,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,1.02 [0.85-1.21],0.86479368884698,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPR15L,Protein GPR15L,Inverse variance weighted,13,1 [0.96-1.05],0.86505731808866,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.99 [0.88-1.12],0.865870057950971,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.01 [0.94-1.08],0.866297477635836,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.96 [0.57-1.62],0.866342203934383,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,1 [0.97-1.04],0.867006144122277,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH15,Cadherin-15,Inverse variance weighted,4,1.01 [0.86-1.19],0.867227672915133,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ERBB3,Receptor tyrosine-protein kinase erbB-3,Inverse variance weighted,11,0.99 [0.89-1.1],0.868628497357478,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,Wald ratio,1,1.03 [0.75-1.4],0.86882353881522,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,STC2,Stanniocalcin-2,Inverse variance weighted,10,1.01 [0.89-1.15],0.870588528171772,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SRP14,Signal recognition particle 14 kDa protein,Inverse variance weighted,3,0.99 [0.88-1.12],0.872156771104705,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.02 [0.82-1.27],0.875381495440491,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,1.01 [0.93-1.09],0.878282138376513,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ARSB,Arylsulfatase B,Inverse variance weighted,9,1.01 [0.93-1.09],0.879404150145823,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,0.97 [0.66-1.42],0.881813069851336,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.01 [0.93-1.09],0.882413118204473,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.99 [0.91-1.09],0.883244554989748,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.03 [0.68-1.56],0.887828434547456,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1 [0.96-1.05],0.888508379765107,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPPK1,Epiplakin,Inverse variance weighted,30,1 [0.98-1.02],0.888666766455765,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ZBP1,Z-DNA-binding protein 1,Inverse variance weighted,6,1 [0.94-1.07],0.890390726154093,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.01 [0.84-1.23],0.891317289921985,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Wald ratio,1,1.01 [0.85-1.21],0.891717125174488,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CTSV,Cathepsin L2,Inverse variance weighted,34,1 [0.95-1.07],0.891879638664008,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1 [0.94-1.07],0.89323099354334,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.98 [0.72-1.33],0.897525304056342,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1 [0.97-1.04],0.899726651652359,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1 [0.95-1.05],0.899977710457976,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,15,1 [0.97-1.04],0.901179421799187,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,1 [0.94-1.07],0.903526904649844,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,18,1 [0.95-1.05],0.904696178552167,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1 [0.95-1.04],0.905944192484346,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.01 [0.81-1.27],0.905986524527931,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,Inverse variance weighted,4,1.01 [0.83-1.23],0.908160336956432,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,C3,Complement C3,Inverse variance weighted,2,0.99 [0.88-1.12],0.908463553511335,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,STX8,Syntaxin-8,Wald ratio,1,0.99 [0.87-1.14],0.908779667726485,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1 [0.95-1.06],0.909138375342351,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,0.99 [0.87-1.13],0.910951927565826,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KLK8,Kallikrein-8,Inverse variance weighted,5,0.99 [0.89-1.11],0.912259572656891,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CFHR2,Complement factor H-related protein 2,Inverse variance weighted,22,1 [0.97-1.03],0.914979101126397,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PGF,Placenta growth factor,Inverse variance weighted,5,0.99 [0.86-1.14],0.915774751013155,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GAST,Gastrin,Inverse variance weighted,9,1.01 [0.88-1.15],0.916337962098003,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CNTN5,Contactin-5,Inverse variance weighted,22,1 [0.94-1.05],0.91707087001156,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,OCLN,Occludin,Inverse variance weighted,2,0.99 [0.84-1.18],0.917353528294308,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.01 [0.91-1.11],0.918690240798841,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.01 [0.86-1.18],0.920400295976056,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,1.02 [0.73-1.41],0.924029205890293,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,F11R,Junctional adhesion molecule A,Inverse variance weighted,3,0.99 [0.87-1.14],0.924039718917767,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,QDPR,Dihydropteridine reductase,Wald ratio,1,0.97 [0.51-1.86],0.924428511382981,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1 [0.98-1.02],0.925329595698811,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1 [0.96-1.05],0.926055861202935,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1 [0.94-1.07],0.926177625975067,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCL2,Apoptosis regulator Bcl-2,Inverse variance weighted,5,0.98 [0.7-1.39],0.928007985397638,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CFH,Complement factor H,Inverse variance weighted,7,1 [0.93-1.07],0.92815475075934,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.99 [0.87-1.13],0.928550480478367,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1 [0.95-1.06],0.928700207514867,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.98 [0.56-1.69],0.928737206808263,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CDH3,Cadherin-3,Inverse variance weighted,10,0.99 [0.75-1.29],0.929059022824752,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ANG,Angiogenin,Inverse variance weighted,9,1.01 [0.84-1.21],0.929189462900176,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.01 [0.89-1.13],0.929417430619997,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.01 [0.87-1.16],0.93089747120575,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.99 [0.74-1.31],0.932746989827502,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,GOLM2,Protein GOLM2,Inverse variance weighted,14,1 [0.93-1.07],0.93362326882218,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CALCA,Calcitonin,Inverse variance weighted,13,1.01 [0.84-1.2],0.935270436929799,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1 [0.95-1.05],0.935810036731254,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1 [0.9-1.11],0.936918050753305,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.99 [0.81-1.21],0.937325576331667,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,1 [0.91-1.09],0.938311325841977,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RSPO3,R-spondin-3,Inverse variance weighted,5,0.99 [0.79-1.25],0.939825845359953,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.99 [0.83-1.19],0.940401904840175,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1 [0.91-1.1],0.942461260964591,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1 [0.93-1.08],0.943047640756703,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1 [0.94-1.06],0.944327465353857,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.98 [0.61-1.59],0.94498054160087,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.99 [0.84-1.18],0.945626283029953,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.99 [0.85-1.17],0.946302249351088,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,1 [0.94-1.06],0.946980324698946,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DCN,Decorin,Inverse variance weighted,2,1.01 [0.72-1.43],0.948237965709869,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,1 [0.94-1.06],0.948876801869508,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,0.99 [0.82-1.2],0.949307697010092,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Wald ratio,1,0.99 [0.71-1.37],0.949945110486861,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.99 [0.74-1.33],0.953159076019938,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",Inverse variance weighted,17,1 [0.96-1.05],0.956011964143759,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HPSE,Heparanase,Inverse variance weighted,7,1 [0.91-1.1],0.956602876063637,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1 [0.88-1.14],0.959142963404225,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CRISP2,Cysteine-rich secretory protein 2,Inverse variance weighted,58,1 [0.96-1.04],0.959616963488322,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,1.01 [0.82-1.23],0.960054003576024,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CNTN3,Contactin-3,Inverse variance weighted,20,1 [0.9-1.11],0.963145054538891,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TF,Serotransferrin,Inverse variance weighted,6,1 [0.87-1.15],0.963427769587692,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1 [0.92-1.08],0.963942716683568,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGAM,Integrin alpha-M,Inverse variance weighted,12,1 [0.93-1.07],0.967879766827242,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1 [0.94-1.07],0.968111008262665,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CLGN,Calmegin,Inverse variance weighted,6,1 [0.94-1.07],0.968827175293694,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,1.01 [0.67-1.5],0.970597572890088,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,25,1 [0.93-1.07],0.972236697987537,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1 [0.84-1.2],0.973212621934645,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,TRIAP1,TP53-regulated inhibitor of apoptosis 1,Inverse variance weighted,9,1 [0.89-1.13],0.974071659967553,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1 [0.87-1.16],0.975447237108181,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.02 [0.36-2.89],0.975886921747012,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,6,1 [0.9-1.1],0.976338567545708,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1 [0.93-1.07],0.977386001387478,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1 [0.97-1.03],0.980401434129868,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,1 [0.9-1.12],0.985613583567882,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,ITGA2,Integrin alpha-2,Inverse variance weighted,13,1 [0.9-1.12],0.98677774596571,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,FCN1,Ficolin-1,Inverse variance weighted,50,1 [0.97-1.03],0.988214477481616,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1 [0.87-1.15],0.98822075271723,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,F9,Coagulation factor IX,Inverse variance weighted,3,1 [0.85-1.18],0.988647341443761,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1 [0.91-1.1],0.991285363570396,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1 [0.85-1.18],0.991448751859621,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1 [0.93-1.07],0.992245837579692,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",Inverse variance weighted,18,1 [0.9-1.11],0.992634967246233,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,CCN5,CCN family member 5,Inverse variance weighted,12,1 [0.96-1.04],0.999213436226682,trans
